https://curecurrent.com/trials/vaccine-and-antibody-treatment-of-prostate-cancer-59001https://curecurrent.com/trials/the-effect-of-exercise-on-tumor-hypoxia-in-men-with-localized-prostate-cancer-undergoing-radical-prostatectomy-59002https://curecurrent.com/trials/study-of-docetaxel-with-doxercalciferol-or-placebo-for-advanced-prostate-cancer-59003https://curecurrent.com/trials/a-pilot-study-of-remote-monitoring-to-improve-health-related-quality-of-life-of-men-following-prostate-cancer-treatment-59004https://curecurrent.com/trials/doxercalciferol-before-surgery-in-treating-localized-prostate-cancer-59005https://curecurrent.com/trials/development-of-urologic-registry-for-personalized-medicine-in-patients-with-urological-malignancy-by-analyzing-circulati-59006https://curecurrent.com/trials/perillyl-alcohol-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-59007https://curecurrent.com/trials/incorporating-mr-imaging-into-prostate-radiotherapy-treatment-planning-59008https://curecurrent.com/trials/deep-learning-for-prostate-segmentation-59009https://curecurrent.com/trials/naf-positron-emission-tomography-computed-tomography-pet-ct-imaging-to-assess-treatment-responsiveness-to-tak-700-in-pat-59010https://curecurrent.com/trials/induction-and-maintenance-of-castration-after-subcutaneous-injections-of-triptorelin-pamoate-in-patients-with-prostate-c-59011https://curecurrent.com/trials/camprobe-developing-a-safer-and-simple-device-for-local-anaesthetic-transperineal-prostate-biopsies-59012https://curecurrent.com/trials/a-canadian-observational-study-in-metastatic-cancer-of-the-prostate-a-study-of-zytiga-use-in-the-community-urology-setti-59013https://curecurrent.com/trials/abiraterone-acetate-plus-lhrh-agonist-and-abiraterone-acetate-plus-lhrh-agonist-and-enzalutamide-59014https://curecurrent.com/trials/177lu-psma-i-t-psma-radioligand-therapy-in-metastatic-castration-resistant-prostate-cancer-59015https://curecurrent.com/trials/circulating-micro-rna-mirna-and-ar-v7-mutational-status-in-metastatic-castration-resistant-prostate-cancer-crpc-primera-59016https://curecurrent.com/trials/real-time-mri-fused-to-cone-beam-ct-guided-biopsies-of-the-prostate-59017https://curecurrent.com/trials/vitamin-d-and-prostate-cancer-a-clinical-study-enrolling-subjects-undergoing-prostatectomy-59018https://curecurrent.com/trials/cardiovascular-events-in-gnrh-agonist-vs-antagonist-59019https://curecurrent.com/trials/gallium-68-psma-11-pet-in-patients-with-biochemical-recurrence-59020https://curecurrent.com/trials/misobold-prostate-cancer-hypoxia-using-bold-mri-and-18f-miso-pet-imaging-59021https://curecurrent.com/trials/neoadjuvant-stereotactic-body-radiotherapy-prior-to-radical-prostatectomy-for-high-risk-prostate-cancer-59022https://curecurrent.com/trials/zometa-on-bone-mineral-density-in-prostate-cancer-patients-undergoing-androgen-ablation-therapy-59023https://curecurrent.com/trials/personalized-mini-pdx-for-metastatic-crpc-59024https://curecurrent.com/trials/functional-mri-use-in-prostate-radiation-treatment-planning-59025https://curecurrent.com/trials/study-of-robotic-template-guidance-for-needle-placement-in-transperineal-prostate-brachytherapy-59026https://curecurrent.com/trials/phase-i-ii-hypofractionated-radiotherapy-for-prostate-cancer-59027https://curecurrent.com/trials/clinical-validity-and-utility-of-genomic-targeted-chemoprevention-of-pca-aim-4a-59028https://curecurrent.com/trials/a-proof-of-concept-study-of-maintenance-therapy-with-tasquinimod-in-patients-with-metastatic-castrate-resistant-prostate-59029https://curecurrent.com/trials/abi-008-trial-in-patients-with-hormone-refractory-prostate-cancer-59030https://curecurrent.com/trials/study-to-assess-the-non-inferiority-of-pamorelin-11-25mg-sc-injected-versus-pamorelin-11-25mg-im-injected-in-patients-su-59031https://curecurrent.com/trials/study-of-lanreotide-in-non-metastatic-castration-resistant-prostate-cancer-patients-59032https://curecurrent.com/trials/study-to-evaluate-a-subcutaneous-four-months-sustained-release-formulation-of-triptorelin-in-patients-with-prostate-canc-59033https://curecurrent.com/trials/ketoconazole-plus-docetaxel-to-treat-prostate-cancer-59034https://curecurrent.com/trials/two-arm-study-of-a-dna-vaccine-encoding-prostatic-acid-phosphatase-pap-in-patients-with-non-metastatic-castrate-resistan-59035https://curecurrent.com/trials/cp-675-206-in-combination-with-short-term-androgen-deprivation-in-patients-with-stage-d0-prostate-cancer-59036https://curecurrent.com/trials/modifications-to-radical-prostatectomy-feasibility-study-59037https://curecurrent.com/trials/quality-of-life-study-using-gabapentin-versus-venlafaxine-in-treating-hot-flashes-in-patients-with-prostate-cancer-59038https://curecurrent.com/trials/zd4054-with-positron-emission-tomography-magnetic-resonance-imaging-pet-mri-for-prostate-cancer-59039https://curecurrent.com/trials/dual-mtor-inhibitor-mln0128-in-advanced-castration-resistant-prostate-cancer-crpc-patients-59040https://curecurrent.com/trials/intermittent-chemotherapy-with-or-without-granulocyte-macrophage-colony-stimulating-factor-gm-csf-for-metastatic-hormone-59041https://curecurrent.com/trials/pharmacodynamic-study-with-flt-pet-ct-in-patients-with-prostate-other-solid-malignancies-treated-with-high-dose-axitinib-59042https://curecurrent.com/trials/the-effects-of-lycopene-on-high-risk-prostatic-tissue-59043https://curecurrent.com/trials/prostatic-acid-phosphatase-pap-vaccine-in-patients-with-prostate-cancer-59044https://curecurrent.com/trials/therapeutics-in-active-prostate-cancer-surveillance-59045https://curecurrent.com/trials/sodium-fluoride-naf-positron-emission-tomography-computed-tomography-pet-ct-in-patients-with-metastatic-castrate-resista-59046https://curecurrent.com/trials/a-research-study-for-patients-with-prostate-cancer-59047https://curecurrent.com/trials/continuation-trial-evaluating-the-tolerability-and-activity-of-fk228-in-patients-that-completed-prior-study-with-fk228-59048https://curecurrent.com/trials/lutetium-177-psma-617-in-low-volume-metastatic-prostate-cancer-59049https://curecurrent.com/trials/natural-dendritic-cells-for-immunotherapy-of-chemo-naive-metastatic-castration-resistant-prostate-cancer-patients-59050https://curecurrent.com/trials/the-role-of-social-comparisons-in-coping-and-quality-of-life-following-a-prostate-cancer-diagnosis-59051https://curecurrent.com/trials/a-registry-to-observe-the-treatment-of-prostate-cancer-under-routine-medical-care-59052https://curecurrent.com/trials/head-to-head-comparison-of-68ga-ga-psma-11-with-18f-psma-1007-pet-ct-in-staging-prostate-cancer-using-histopathology-and-59053https://curecurrent.com/trials/charit-ht-prostate-59054https://curecurrent.com/trials/cabozantinib-plus-docetaxel-and-prednisone-for-advanced-prostate-cancer-59055https://curecurrent.com/trials/denosumab-plus-enzalutamide-abiraterone-and-prednisone-compared-to-denosumab-plus-enzalutamide-alone-for-men-with-castra-59056https://curecurrent.com/trials/applying-pet-mr-in-oncology-a-prospective-project-59057https://curecurrent.com/trials/evaluation-of-the-effect-of-psycho-oncological-intervention-on-well-being-of-patients-with-advanced-prostate-cancer-on-l-59058https://curecurrent.com/trials/combination-of-68ga-psma-pet-data-with-magnetic-resonance-spectroscopy-data-mrs-for-evaluating-prostate-cancer-59059https://curecurrent.com/trials/precise-therapy-for-mcrpc-patients-through-whole-exome-sequencing-pttwes-59060https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-recurrent-prostate-cancer-59061https://curecurrent.com/trials/structural-network-on-prostate-cancer-in-the-french-greater-west-region-59062https://curecurrent.com/trials/paclitaxel-and-bryostatin-1-in-treating-patients-with-metastatic-prostate-cancer-59063https://curecurrent.com/trials/a-trial-of-paclitaxel-albumin-binding-for-castration-resistant-prostate-cancer-59064https://curecurrent.com/trials/combination-chemotherapy-plus-peripheral-stem-cell-transplantation-in-treating-patients-with-metastatic-prostate-cancer-59065https://curecurrent.com/trials/tributyrin-in-treating-patients-with-refractory-prostate-cancer-or-other-solid-tumors-59066https://curecurrent.com/trials/using-promis-as-part-of-routine-clinical-care-for-racially-diverse-prostate-and-bladder-cancer-patients-59067https://curecurrent.com/trials/quantification-of-respiratory-induced-prostate-motion-59068https://curecurrent.com/trials/study-of-taxotere-and-doxil-to-treat-advanced-androgen-independent-prostate-cancer-59069https://curecurrent.com/trials/bioprop20-biologically-optimised-imrt-for-prostate-radiotherapy-hypofractionated-radiotherapy-with-intra-prostatic-boost-59070https://curecurrent.com/trials/phase-i-clinical-trial-of-cryoimmunotherapy-against-prostate-cancer-59071https://curecurrent.com/trials/radical-prostatectomy-versus-radical-radiotherapy-for-locally-advanced-prostate-cancer-59072https://curecurrent.com/trials/using-decision-analysis-to-enhance-decision-making-regarding-prostate-cancer-screening-59073https://curecurrent.com/trials/qudratus-lumborum-block-for-postoperative-pain-after-endoscopic-prostatectomy-59074https://curecurrent.com/trials/enzalutamide-and-niraparib-in-the-treatment-of-metastatic-castrate-resistant-prostate-cancer-crpc-59075https://curecurrent.com/trials/4kscore-using-serum-stored-uncentrifuged-59076https://curecurrent.com/trials/upar-pet-ct-in-radium-223-dichloride-treatment-of-patients-with-metastatic-castration-resistant-prostate-cancer-59077https://curecurrent.com/trials/unfavorable-mri-but-favorable-68ga-psma-pet-mri-for-primary-prostate-cancer-detection-59078https://curecurrent.com/trials/targeted-biopsy-or-standard-biopsy-for-clinical-significant-prostate-cancer-detection-59079https://curecurrent.com/trials/virtual-environment-radiotherapy-to-improve-patients-compliance-to-radiotherapy-rt-in-prostate-cancer-59080https://curecurrent.com/trials/safety-study-of-bpx-201-dendritic-cell-vaccine-plus-ap1903-in-metastatic-castrate-resistent-prostate-cancer-59081https://curecurrent.com/trials/mtd-study-of-vaccine-bp-gmax-cd1-plus-ap1903-to-treat-castrate-resistant-prostate-cancer-59082https://curecurrent.com/trials/fluciclovine-18f-pet-ct-in-biochemical-recurrence-of-prostate-cancer-59083https://curecurrent.com/trials/using-psma-pet-ct-as-a-diagnostic-tool-for-detection-of-prostatic-cancer-at-an-early-stage-59084https://curecurrent.com/trials/study-of-polyphenon-e-in-men-with-high-grade-prostatic-intraepithelial-neoplasia-59085https://curecurrent.com/trials/safety-and-efficacy-study-of-dose-escalated-hypofractionated-radiotherapy-for-prostate-cancer-59086https://curecurrent.com/trials/psma-and-tarp-peptide-vaccine-with-poly-ic-lc-adjuvant-in-hla-a2-patients-with-elevated-psa-after-initial-definitive-tre-59087https://curecurrent.com/trials/a-phase-1-study-of-mdv3100-in-patients-with-castration-resistant-hormone-refractory-prostate-cancer-59088https://curecurrent.com/trials/feasibility-study-for-the-assessment-of-sleep-quality-in-men-with-prostate-cancer-starting-adt-59089https://curecurrent.com/trials/choline-pet-ct-and-mri-for-targeted-prostate-biopsy-59090https://curecurrent.com/trials/safety-and-tolerability-analysis-of-combining-desmopressin-with-docetaxel-for-the-treatment-of-castration-resistant-pros-59091https://curecurrent.com/trials/phenelzine-sulfate-and-docetaxel-in-treating-patients-with-prostate-cancer-with-progressive-disease-after-first-line-the-59092https://curecurrent.com/trials/living-with-prostate-cancer-lpc-59093https://curecurrent.com/trials/intimacy-and-mindfulness-post-prostate-cancer-treatment-59094https://curecurrent.com/trials/mri-versus-psa-in-prostate-cancer-screening-59095https://curecurrent.com/trials/radical-prostatectomy-and-external-beam-radiotherapy-in-mcrpc-with-223radium-dicloride-raprorad-59096https://curecurrent.com/trials/whether-transperineal-prostate-biopsy-under-local-anaesthesia-using-a-transperineal-access-system-is-non-inferior-to-sta-59097https://curecurrent.com/trials/saw-palmetto-symptom-management-for-men-during-radiation-therapy-59098https://curecurrent.com/trials/first-in-man-dose-escalation-study-of-bay2010112-in-patients-with-prostate-cancer-59099https://curecurrent.com/trials/single-center-trial-for-the-validation-of-high-resolution-transrectal-ultrasound-exact-imaging-scanner-exactvu-for-the-d-59100https://curecurrent.com/trials/study-of-mr-based-igrt-for-prostate-cancer-59101https://curecurrent.com/trials/measurement-of-circulating-tumor-cells-in-prostate-cancer-59102https://curecurrent.com/trials/safety-and-tolerability-of-atezolizumab-atz-in-combination-with-radium-223-dichloride-r-223-d-in-metastatic-castrate-res-59103https://curecurrent.com/trials/analyze-the-predictive-value-of-gene-tmprss2-ets-in-response-to-enzalutamide-in-patients-with-prostate-cancer-59104https://curecurrent.com/trials/conventional-ultrasound-for-imaging-of-prostate-cancer-extent-and-response-in-human-cancer-patients-59105https://curecurrent.com/trials/firmagon-degarelix-intermittent-therapy-59106https://curecurrent.com/trials/eradication-of-prostate-cancer-using-f-989-59107https://curecurrent.com/trials/a-study-of-olaratumab-imc-3g3-in-prostate-cancer-59108https://curecurrent.com/trials/preservation-of-endopelvic-fascia-effects-on-postoperative-incontinence-and-impotence-randomized-clinical-trial-59109https://curecurrent.com/trials/study-to-assess-the-efficacy-of-brachytherapy-with-or-without-hormone-therapy-using-triptorelin-22-5mg-in-patients-with-59110https://curecurrent.com/trials/fusion-targeted-biopsy-of-the-prostate-59111https://curecurrent.com/trials/optimizing-abiraterone-therapy-59112https://curecurrent.com/trials/phase-i-study-of-intensity-modulated-radiation-therapy-for-prostate-cancer-59113https://curecurrent.com/trials/prediction-of-the-risk-of-biochemical-relapse-after-radical-prostatectomy-for-prostate-cancer-using-radomics-on-pre-ther-59114https://curecurrent.com/trials/value-of-flt-pet-ct-in-radium-223-therapy-of-mcrpc-patients-59115https://curecurrent.com/trials/miami-membrane-for-potency-mmep-trial-59116https://curecurrent.com/trials/exercise-and-quality-of-life-during-androgen-deprivation-therapy-59117https://curecurrent.com/trials/tki258-in-castrate-resistant-prostate-cancer-59118https://curecurrent.com/trials/genistein-in-treating-patients-with-prostate-cancer-59119https://curecurrent.com/trials/study-of-ferumoxytol-enhanced-mri-for-detecting-lymph-node-metastases-in-prostate-bladder-and-kidney-cancers-59120https://curecurrent.com/trials/predicting-prostate-cancer-in-elderly-men-59121https://curecurrent.com/trials/mirabegron-for-treatment-of-erectile-dysfunction-in-patients-with-luts-secondry-to-bph-a-randomized-study-59122https://curecurrent.com/trials/a-randomized-double-blind-phase-3-efficacy-trial-of-prostvac-v-f-gm-csf-in-men-with-asymptomatic-or-minimally-symptomati-59123https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-low-and-intermediate-risk-prostate-cancer-59124https://curecurrent.com/trials/tangerine-or-red-tomato-juice-in-treating-patients-with-prostate-cancer-undergoing-surgery-59125https://curecurrent.com/trials/taste-acceptability-of-tomato-soy-arugula-seed-beverages-in-men-with-prostate-cancer-59126https://curecurrent.com/trials/supervised-group-based-exercise-for-men-with-prostate-cancer-on-androgen-deprivation-therapy-59127https://curecurrent.com/trials/study-of-olaparib-degarelix-given-to-men-with-intermediate-high-risk-prostate-cancer-before-prostatectomy-59128https://curecurrent.com/trials/radtox-measuring-radiation-toxicity-using-circulating-dna-59129https://curecurrent.com/trials/exercise-for-prostate-cancer-patients-59130https://curecurrent.com/trials/study-of-es414-in-metastatic-castration-resistant-prostate-cancer-59131https://curecurrent.com/trials/safety-and-efficacy-study-of-ipilimumab-3-mg-kg-versus-ipilimumab-10-mg-kg-in-subjects-with-metastatic-castration-resist-59132https://curecurrent.com/trials/positive-imaging-study-for-distant-metastases-in-patients-with-castration-resistant-prostate-cancer-59133https://curecurrent.com/trials/physical-activity-in-men-newly-diagnosed-with-prostate-cancer-a-feasibility-study-59134https://curecurrent.com/trials/stereotactic-radiation-therapy-in-treating-patients-with-prostate-cancer-59135https://curecurrent.com/trials/high-intensity-focused-ultrasound-in-treating-participants-with-intermediate-and-high-risk-prostate-cancer-59136https://curecurrent.com/trials/temsirolimus-and-bevacizumab-in-hormone-resistant-metastatic-prostate-cancer-that-did-not-respond-to-chemotherapy-59137https://curecurrent.com/trials/trial-of-nanopac-focal-therapy-in-subjects-with-prostate-cancer-59138https://curecurrent.com/trials/immune-monitoring-protocol-in-men-with-prostate-cancer-enrolled-in-a-clinical-trial-of-sipuleucel-t-59139https://curecurrent.com/trials/i125-brachytherapy-after-turp-59140https://curecurrent.com/trials/toparp-a-phase-ii-trial-of-olaparib-in-patients-with-advanced-castration-resistant-prostate-cancer-59141https://curecurrent.com/trials/study-of-abiraterone-acetate-in-subjects-with-metastatic-castration-resistant-prostate-cancer-59142https://curecurrent.com/trials/prostate-health-index-for-prostate-cancer-diagnosis-59143https://curecurrent.com/trials/dose-escalation-using-fiducial-markers-in-image-guided-volumetric-modulated-arc-therapy-to-the-focal-lesion-micro-boost-59144https://curecurrent.com/trials/biparametric-mri-for-detection-of-significant-prostate-cancer-59145https://curecurrent.com/trials/metformin-hydrochloride-as-first-line-therapy-in-treating-patients-with-locally-advanced-or-metastatic-prostate-cancer-59146https://curecurrent.com/trials/everolimus-as-first-line-therapy-in-treating-patients-with-prostate-cancer-59147https://curecurrent.com/trials/molecular-pet-mr-imaging-in-vivo-validation-of-biomarker-for-human-prostate-cancer-59148https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-the-bioprotect-balloon-in-prostate-cancer-subjects-undergoing-radiotherapy-59149https://curecurrent.com/trials/asia-study-group-of-prostate-cancer-a-cap-study-59150https://curecurrent.com/trials/internal-radiation-therapy-with-or-without-external-beam-radiation-therapy-in-treating-patients-with-localized-prostate-59151https://curecurrent.com/trials/multi-institutional-registry-for-prostate-cancer-radiosurgery-59152https://curecurrent.com/trials/early-urinary-continence-after-radical-prostatectomy-surgical-procedure-and-anatomic-landmarks-59153https://curecurrent.com/trials/phase-ii-clinical-trial-of-purified-isoflavones-in-prostate-cancer-comparing-safety-effectiveness-59154https://curecurrent.com/trials/ketoconazole-hydrocortisone-and-gm-csf-in-treating-patients-with-progressive-prostate-cancer-after-hormone-therapy-59155https://curecurrent.com/trials/a-pilot-study-of-hormonal-therapy-combined-with-central-memory-t-cells-tcm-for-patients-with-advanced-prostate-cancer-59156https://curecurrent.com/trials/safety-study-of-apr-246-in-patients-with-refractory-hematologic-cancer-or-prostate-cancer-59157https://curecurrent.com/trials/changes-in-body-composition-with-patients-under-androgen-deprivation-therapy-59158https://curecurrent.com/trials/study-of-tak-700-in-combination-with-docetaxel-and-prednisone-in-men-with-metastatic-castration-resistant-prostate-cance-59159https://curecurrent.com/trials/study-of-focal-cryoablation-in-low-risk-prostate-cancer-59160https://curecurrent.com/trials/study-to-assess-renewal-of-treatment-in-patients-recently-diagnosed-with-prostate-cancer-59161https://curecurrent.com/trials/mri-guided-radiation-therapy-in-treating-patients-who-have-undergone-surgery-to-remove-the-prostate-59162https://curecurrent.com/trials/a-phase-ii-trial-of-cyberknife-stereotactic-radiosurgery-to-prostate-tumors-59163https://curecurrent.com/trials/single-dose-radiotherapy-sdrt-with-or-without-adjuvant-systemic-therapy-for-oligometastatic-prostate-cancer-59164https://curecurrent.com/trials/postoperative-radiation-therapy-hormonal-therapy-and-concurrent-docetaxel-for-high-risk-pathologic-prostate-cancer-59165https://curecurrent.com/trials/a-randomized-phase-iia-efficacy-and-safety-study-of-radium-223-dichloride-with-abiraterone-acetate-or-enzalutamide-in-me-59166https://curecurrent.com/trials/phase-ii-study-of-ultra-high-dose-hypofractionated-vs-single-dose-image-guided-radiotherapy-for-prostate-cancer-59167https://curecurrent.com/trials/quality-of-life-and-sexuality-in-patients-with-prostate-cancer-59168https://curecurrent.com/trials/stereotactic-hypofractionated-accelerated-radiotherapy-post-prostatectomy-59169https://curecurrent.com/trials/study-of-the-efficacy-safety-and-pharmacokinetics-of-sm88-in-patients-with-prostate-cancer-59170https://curecurrent.com/trials/intensity-modulated-radiation-therapy-for-prostate-cancer-59171https://curecurrent.com/trials/mr-trus-fusion-guided-prostate-biopsy-59172https://curecurrent.com/trials/a-study-of-abiraterone-acetate-plus-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer-who-have-59173https://curecurrent.com/trials/ga-68-psma-ligand-a-radiopharmaceutical-for-localization-of-prostate-cancer-59174https://curecurrent.com/trials/investigating-the-effects-of-azd2014-therapy-given-prior-to-radical-prostatectomy-in-men-with-high-risk-prostate-cancer-59175https://curecurrent.com/trials/explaining-the-invisible-using-the-pearl-system-59176https://curecurrent.com/trials/therapy-for-erectile-dysfunction-adaptation-of-act-for-compliance-with-an-erectile-rehabilitation-program-59177https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-stage-i-iii-prostate-cancer-59178https://curecurrent.com/trials/standard-dose-versus-high-dose-and-versus-extended-standard-dose-radium-223-dichloride-in-castration-resistant-prostate-59179https://curecurrent.com/trials/efficacy-and-safety-study-of-tookad-soluble-for-localised-prostate-cancer-compared-to-active-surveillance-59180https://curecurrent.com/trials/claricore-system-used-in-transperineal-prostate-biopsy-59181https://curecurrent.com/trials/sipuleucel-t-ct-011-and-cyclophosphamide-for-advanced-prostate-cancer-59182https://curecurrent.com/trials/ctc-immune-checkpoint-59183https://curecurrent.com/trials/cyt107-after-vaccine-treatment-provenge-in-patients-with-metastatic-castration-resistant-prostate-cancer-59184https://curecurrent.com/trials/androgen-deprivation-therapy-external-beam-radiotherapy-and-stereotactic-radiosurgery-boost-for-prostate-cancer-59185https://curecurrent.com/trials/abiraterone-with-different-steroid-regimens-for-side-effect-related-to-mineralcorticoid-excess-prevention-in-prostate-ca-59186https://curecurrent.com/trials/therapy-pathways-in-the-treatment-of-hormone-na-ve-prostate-cancer-patients-with-and-without-comorbidities-treated-with-59187https://curecurrent.com/trials/culturally-tailored-decision-aid-for-hispanic-patients-diagnosed-with-prostate-cancer-59188https://curecurrent.com/trials/prostate-margin-reduction-to-reduce-acute-rectal-toxicity-protract-59189https://curecurrent.com/trials/measurement-of-natural-killer-cell-activity-in-whole-blood-in-men-being-screened-for-prostate-cancer-with-biopsy-59190https://curecurrent.com/trials/food-effect-study-of-abiraterone-acetate-for-treatment-of-patients-with-castration-resistant-prostate-cancer-59191https://curecurrent.com/trials/whole-body-vibration-and-pelvic-floor-exercises-on-urinary-incontinence-59192https://curecurrent.com/trials/prevention-of-micro-architectural-bone-decay-in-males-with-non-metastatic-prostate-cancer-receiving-androgen-deprivation-59193https://curecurrent.com/trials/intensity-modulated-external-beam-radiation-therapy-in-treating-patients-with-prostate-cancer-59194https://curecurrent.com/trials/a-study-of-the-effect-of-enantone-lp-11-25-mg-leuprorelin-on-the-histological-progression-of-indolent-prostate-cancer-59195https://curecurrent.com/trials/initial-experience-in-brazilian-single-center-with-high-intensity-focalized-ultrasound-hifu-prostate-cancer-therapy-morb-59196https://curecurrent.com/trials/vinorelbine-in-treating-patients-with-metastatic-prostate-cancer-59197https://curecurrent.com/trials/capecitabine-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-59198https://curecurrent.com/trials/salvage-therapeutic-radiation-with-enzalutamide-and-adt-in-men-with-recurrent-prostate-cancer-stream-59199https://curecurrent.com/trials/defining-recurrent-disease-with-axumin-59200https://curecurrent.com/trials/phase-ii-investigation-of-prostate-artery-embolization-pae-before-radical-prostatectomy-in-prostate-cancer-patients-59201https://curecurrent.com/trials/a-safety-study-in-patients-with-advanced-prostate-cancer-treated-with-firmagon-59202https://curecurrent.com/trials/cabazitaxel-versus-the-switch-to-alternative-ar-targeted-therapy-enzalutamide-or-abiraterone-in-metastatic-castration-re-59203https://curecurrent.com/trials/lde225-docetaxel-prednisone-for-adv-met-castrate-resistant-prostate-cancer-w-disease-progression-after-docetaxel-59204https://curecurrent.com/trials/resistance-training-and-protein-supplementation-for-prostate-cancer-survivors-59205https://curecurrent.com/trials/role-of-soy-supplementation-in-prostate-cancer-development-59206https://curecurrent.com/trials/comparison-of-explicit-implicit-and-no-values-clarification-decision-aids-for-men-considering-prostate-cancer-screening-59207https://curecurrent.com/trials/cixutumumab-and-temsirolimus-in-treating-patients-with-metastatic-prostate-cancer-59208https://curecurrent.com/trials/safety-and-efficacy-of-firmagon-degarelix-for-injection-59209https://curecurrent.com/trials/rectal-gas-removal-through-small-catheter-placement-prior-to-mri-of-the-prostate-59210https://curecurrent.com/trials/testing-radical-prostatectomy-in-chinese-men-with-prostate-cancer-and-oligometastases-to-the-bone-59211https://curecurrent.com/trials/adequacy-of-prostate-specific-antigen-psa-requests-59212https://curecurrent.com/trials/examination-of-focal-therapies-mri-fusion-hifu-nanoknife-and-cryotherapy-59213https://curecurrent.com/trials/assessing-the-impact-of-incorporating-charlson-comorbidity-scores-on-patient-anxiety-and-satisfaction-59214https://curecurrent.com/trials/endothelial-function-in-prostate-cancer-patients-on-degarelix-vs-luteinizing-hormone-releasing-hormone-agonists-59215https://curecurrent.com/trials/factors-associated-with-psa-false-negative-and-false-positive-results-and-the-impact-on-patient-s-health-59216https://curecurrent.com/trials/the-effects-of-radium-223-dichloride-therapy-on-radionuclide-bone-scan-lesions-59217https://curecurrent.com/trials/prospective-circulating-prostate-cancer-predictors-in-higher-risk-mcrpc-study-59218https://curecurrent.com/trials/personal-web-page-in-clinical-trial-participant-education-59219https://curecurrent.com/trials/a-registry-of-sipuleucel-t-therapy-in-men-with-advanced-prostate-cancer-59220https://curecurrent.com/trials/prospective-evaluation-of-mp-mri-mr-guided-biopsy-and-molecular-markers-for-active-surveillance-of-prostate-cancer-59221https://curecurrent.com/trials/androgen-deprivation-therapy-adt-versus-adt-plus-prostate-cryotherapy-for-metastatic-prostate-cancer-mpca-59222https://curecurrent.com/trials/efficacy-of-massage-for-the-treatment-of-cancer-related-fatigue-crf-in-prostate-cancer-survivors-59223https://curecurrent.com/trials/cabazitaxel-versus-docetaxel-both-with-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer-59224https://curecurrent.com/trials/detection-of-clinically-significant-prostate-cancer-using-transperineal-targeted-biopsy-compared-to-standard-transrectal-59225https://curecurrent.com/trials/detection-and-localization-of-carcinoma-using-high-resolution-transrectal-imaging-proof-of-concept-study-59226https://curecurrent.com/trials/return-to-work-among-cancer-survivors-with-treatment-induced-survivorship-syndromes-59227https://curecurrent.com/trials/a-study-to-investigate-the-impact-of-abiraterone-acetate-and-enzalutamide-on-health-related-quality-of-life-participant-59228https://curecurrent.com/trials/viberect-penile-vibratory-stimulation-to-enhance-recovery-of-erectile-function-and-urinary-continence-post-prostatectomy-59229https://curecurrent.com/trials/gadoxetate-sodium-enhanced-mri-as-a-biomarker-for-aggressive-prostate-cancer-59230https://curecurrent.com/trials/stereotactic-mr-guided-adaptive-radiation-therapy-for-localized-prostate-cancer-59231https://curecurrent.com/trials/evaluation-of-oncoxin-viusid-in-prostate-cancer-59232https://curecurrent.com/trials/apatinib-in-combination-with-stereotactic-body-radiation-therapy-sbrt-treatment-for-symptomatic-metastatic-prostate-canc-59233https://curecurrent.com/trials/can-hyperbaric-oxygen-improve-erectile-function-following-surgery-for-prostate-cancer-59234https://curecurrent.com/trials/orteronel-maintenance-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-and-non-progressive-disea-59235https://curecurrent.com/trials/urology-of-virginia-case-series-59236https://curecurrent.com/trials/radiation-therapy-for-rising-prostate-specific-antigen-psa-post-prostatectomy-59237https://curecurrent.com/trials/docetaxel-and-cetuximab-in-treating-patients-with-metastatic-prostate-cancer-59238https://curecurrent.com/trials/whole-body-3d-t1-weighted-mr-imaging-anatomical-sequences-ge-mdixon-vs-fse-view-approaches-in-prostate-cancer-59239https://curecurrent.com/trials/improving-erectile-function-and-quality-of-life-after-prostate-cancer-treatment-59240https://curecurrent.com/trials/genetic-biomarker-discovery-for-metastatic-prostate-cancer-59241https://curecurrent.com/trials/targeted-fusion-biopsy-of-the-prostate-59242https://curecurrent.com/trials/incidence-of-second-primary-malignancies-in-castration-resistant-prostate-cancer-an-observational-retrospective-cohort-s-59243https://curecurrent.com/trials/18f-fch-pet-mri-to-assess-tumor-response-in-castration-resistant-prostate-cancer-59244https://curecurrent.com/trials/low-fat-fish-oil-diet-for-prostate-cancer-prevention-59245https://curecurrent.com/trials/optimizing-veteran-centered-prostate-cancer-survivorship-care-59246https://curecurrent.com/trials/psma-pet-ct-for-prostate-cancer-59247https://curecurrent.com/trials/treatment-of-localized-prostate-cancer-with-high-intensity-focused-ultrasound-using-the-sonablate-500-system-in-canada-59248https://curecurrent.com/trials/chemoprevention-of-prostate-cancer-hdac-inhibition-and-dna-methylation-59249https://curecurrent.com/trials/open-anterograde-radical-prostatectomy-compared-to-open-retrograde-technique-59250https://curecurrent.com/trials/randomized-trial-of-image-guided-stereotactic-radiation-therapy-ig-srt-in-prostate-cancer-59251https://curecurrent.com/trials/evaluation-of-the-nv-vpac1-prostate-cancer-pca-urine-diagnostic-test-in-subjects-with-biopsy-confirmed-prostate-cancer-b-59252https://curecurrent.com/trials/prognostic-role-of-free-psa-ratio-at-biochemical-recurrence-after-radical-treatments-for-prostate-cancer-59253https://curecurrent.com/trials/radiation-therapy-androgen-suppression-and-docetaxel-in-treating-patients-with-high-risk-prostate-cancer-who-have-underg-59254https://curecurrent.com/trials/proton-therapy-for-high-risk-prostate-cancer-59255https://curecurrent.com/trials/18f-dcfbc-pet-ct-in-prostate-cancer-59256https://curecurrent.com/trials/ctt1057-a-small-molecular-inhibitor-of-psma-as-a-novel-imaging-agent-of-neovascularization-in-renal-cell-carcinoma-59257https://curecurrent.com/trials/safety-and-tolerability-study-of-mdv3100-in-combination-with-docetaxel-in-men-with-advanced-prostate-cancer-59258https://curecurrent.com/trials/semi-automatic-download-of-prostate-biopsy-cores-while-keeping-the-orientation-unfolding-and-unity-of-the-sample-59259https://curecurrent.com/trials/a-novel-3d-navigation-technology-for-improved-trus-prostate-biopsy-59260https://curecurrent.com/trials/eating-activity-and-stress-education-59261https://curecurrent.com/trials/extend-exercise-trial-59262https://curecurrent.com/trials/evaluation-of-an-online-intervention-in-improving-general-practitioners-practice-in-prostate-cancer-screening-59263https://curecurrent.com/trials/dietary-factors-and-racial-disparities-in-prostate-cancer-aggressiveness-59264https://curecurrent.com/trials/the-assessment-of-the-feasibility-of-a-home-based-exercise-programme-in-the-older-patient-following-major-surgery-59265https://curecurrent.com/trials/zinc-psa-ratio-as-a-novel-biomarker-for-prostate-cancer-detection-59266https://curecurrent.com/trials/study-of-2-different-doses-of-revlimid-in-biochemically-relapse-prostate-cancer-59267https://curecurrent.com/trials/pet-scanning-to-evaluate-zoledronate-efficacy-in-metastatic-prostate-cancer-59268https://curecurrent.com/trials/non-interventional-study-prevent-59269https://curecurrent.com/trials/special-drug-use-surveillance-of-leuplin-pro-for-injection-kit-22-5-mg-for-prostate-cancer-59270https://curecurrent.com/trials/a-multicenter-clinical-study-of-the-sonablate-450-for-the-treatment-of-locally-recurrent-prostate-cancer-with-hifu-star-59271https://curecurrent.com/trials/study-to-evaluate-99mtc-mip-1404-spect-ct-imaging-in-men-with-biopsy-proven-low-grade-prostate-cancer-59272https://curecurrent.com/trials/investigational-study-for-the-treatment-of-localized-t1c-t2a-prostate-cancer-with-high-intensity-focused-ultrasound-hifu-59273https://curecurrent.com/trials/clinical-study-of-the-sonablate-500-to-treat-localized-t1c-t2a-prostate-cancer-59274https://curecurrent.com/trials/intraprostatic-prx302-injection-to-treat-localised-prostate-cancer-59275https://curecurrent.com/trials/high-dose-vitamin-d-supplementation-for-adt-induced-side-effects-59276https://curecurrent.com/trials/use-of-an-experimental-radiopharmaceutical-131i-mip-1095-in-men-with-metastatic-castration-resistant-prostate-cancer-mcr-59277https://curecurrent.com/trials/hypofractionated-image-guided-proton-therapy-for-low-andintermediate-risk-prostate-cancer-59278https://curecurrent.com/trials/effect-of-intravenous-magnesium-during-robot-assisted-prostatectomy-59279https://curecurrent.com/trials/a-study-of-an-experimental-chemotherapy-combination-to-treat-hormone-refractory-prostate-cancer-59280https://curecurrent.com/trials/transrectal-mri-guided-biopsy-in-identifying-cancer-in-patients-with-suspected-prostate-cancer-59281https://curecurrent.com/trials/gm-csf-for-maintenance-of-prostate-cancer-for-patients-responding-to-taxotere-59282https://curecurrent.com/trials/a-neoadjuvant-study-of-androgen-ablation-combined-with-cyclophosphamide-and-gvax-vaccine-for-localized-prostate-cancer-59283https://curecurrent.com/trials/use-of-hypothermia-during-robotic-prostatectomy-59284https://curecurrent.com/trials/study-of-bevacizumab-and-erlotinib-for-patients-with-hormone-refractory-prostate-cancer-59285https://curecurrent.com/trials/pre-prostatectomy-lovastatin-on-prostate-cancer-59286https://curecurrent.com/trials/validation-of-the-prostate-cancer-assay-beta-pivotal-59287https://curecurrent.com/trials/novel-13c-carotenoids-for-absorption-and-metabolism-studies-in-humans-59288https://curecurrent.com/trials/open-label-safety-extension-study-in-patients-who-have-previously-participated-and-have-benefited-from-lmis-50-mg-59289https://curecurrent.com/trials/f-18-fluorothymidine-pet-ct-imaging-for-pelvic-cancers-59290https://curecurrent.com/trials/enzalutamide-in-patients-with-high-risk-prostate-cancer-59291https://curecurrent.com/trials/mr-based-hypofractionated-adaptive-igrt-of-prostate-cancer-m-base-hypro-2-0-59292https://curecurrent.com/trials/concurrent-vs-sequential-sipuleucel-t-abiraterone-treatment-in-men-with-metastatic-castrate-resistant-prostate-cancer-59293https://curecurrent.com/trials/post-eradicate-a-long-term-follow-up-of-subjects-that-completed-the-eradicate-study-nct-02097303-59294https://curecurrent.com/trials/dovitinib-tki258-and-abiraterone-acetate-in-metastatic-castrate-resistant-prostate-cancer-mcrpc-59295https://curecurrent.com/trials/open-label-phase-two-study-of-enzalutamide-with-concurrent-administration-of-radium-ra-223-dichloride-in-castration-resi-59296https://curecurrent.com/trials/89zr-j591-anti-prostate-specific-membrane-antigen-monoclonal-antibody-in-patients-with-glioblastoma-multiforme-59297https://curecurrent.com/trials/a-study-of-abiraterone-acetate-jnj-212082-and-prednisolone-in-patients-with-advanced-prostate-cancer-59298https://curecurrent.com/trials/comparison-of-dir-mri-and-dce-mri-in-detection-of-prostate-cancer-a-pilot-study-59299https://curecurrent.com/trials/the-effect-of-prolonged-inspiratory-time-on-gas-exchange-during-robot-assisted-laparoscopic-surgery-with-steep-trendelen-59300https://curecurrent.com/trials/a-safety-trial-of-mva-bn-pro-in-men-with-androgen-insensitive-prostate-cancer-59301https://curecurrent.com/trials/focal-mr-guided-focused-ultrasound-treatment-of-localized-low-intermediate-risk-prostate-cancer-feasibility-study-59302https://curecurrent.com/trials/sbrt-in-4-fractions-for-prostate-cancer-59303https://curecurrent.com/trials/tumor-hypoxia-with-hx4-pet-in-several-diseases-59304https://curecurrent.com/trials/magnetic-resonance-spectroscopic-imaging-of-the-prostate-at-3-tesla-59305https://curecurrent.com/trials/a-pre-surgical-study-of-lde225-in-men-with-high-risk-localized-prostate-cancer-59306https://curecurrent.com/trials/c11-sodium-acetate-pet-ct-imaging-for-metastatic-disease-in-intermediate-to-high-risk-prostate-adenocarcinoma-59307https://curecurrent.com/trials/pet-imaging-characteristics-of-c11-acetate-in-patients-with-recurrent-prostate-carcinoma-59308https://curecurrent.com/trials/study-of-proscavax-vaccine-in-patients-with-localized-prostate-cancer-vs-active-surveillance-59309https://curecurrent.com/trials/pd-1-knockout-engineered-t-cells-for-castration-resistant-prostate-cancer-59310https://curecurrent.com/trials/impact-of-the-addition-of-metformin-to-abiraterone-in-metastatic-prostate-cancer-patients-59311https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetic-behavior-of-leuprolide-mesylate-in-subjects-with-advanced-prostate-carcinoma-59312https://curecurrent.com/trials/amg-386-and-abiraterone-for-advanced-prostate-cancer-59313https://curecurrent.com/trials/comparison-of-pain-levels-in-fusion-prostate-biopsy-and-standard-trus-guided-biopsy-59314https://curecurrent.com/trials/xbox-kinect-training-in-men-with-prostate-cancer-59315https://curecurrent.com/trials/prolaris-enhanced-risk-stratification-an-economic-and-clinical-evaluation-59316https://curecurrent.com/trials/leuprolide-acetate-or-goserelin-acetate-with-or-without-vismodegib-followed-by-surgery-in-treating-patients-with-locally-59317https://curecurrent.com/trials/relations-between-pelvic-floor-diaphragm-and-trunk-muscles-59318https://curecurrent.com/trials/intensity-modulated-radiation-therapy-in-treating-patients-with-localized-prostate-cancer-59319https://curecurrent.com/trials/trial-of-dasatinib-sprycel-in-subjects-with-hormone-refractory-prostate-cancer-59320https://curecurrent.com/trials/multi-center-trial-of-high-resolution-transrectal-ultrasound-versus-standard-low-resolution-transrectal-ultrasound-for-t-59321https://curecurrent.com/trials/observational-prospective-study-describing-the-global-patient-care-and-follow-up-of-prostate-cancer-patients-treated-wit-59322https://curecurrent.com/trials/18f-dcfpyl-pet-ct-scan-and-prostate-cancer-59323https://curecurrent.com/trials/sirolimus-before-surgery-in-treating-patients-with-advanced-localized-prostate-cancer-59324https://curecurrent.com/trials/web-based-lifestyle-trial-among-men-with-prostate-cancer-prostate-8-59325https://curecurrent.com/trials/claricore-system-used-in-transrectal-ultrasound-guided-prostate-biopsy-for-real-time-tissue-evaluation-59326https://curecurrent.com/trials/monitoring-and-mapping-of-erectile-nerve-during-ralp-mmen-study-59327https://curecurrent.com/trials/telemedicine-clinic-for-prostate-cancer-patients-59328https://curecurrent.com/trials/psma-based-18f-dcfpyl-pet-ct-evaluating-its-application-in-real-life-59329https://curecurrent.com/trials/claricore-biopsy-system-in-patients-undergoing-radical-retropubic-prostatectomy-59330https://curecurrent.com/trials/a-phase-ii-study-of-ara-c-cytarabine-in-men-with-androgen-independent-prostate-cancer-59331https://curecurrent.com/trials/ogx-427-in-castration-resistant-prostate-cancer-patients-59332https://curecurrent.com/trials/a-phase-1-study-of-alisertib-participants-with-advanced-solid-tumors-including-castration-resistant-prostate-cancer-rece-59333https://curecurrent.com/trials/correlation-between-suv-on-18f-dcfpyl-pet-ct-and-gleason-score-in-prostate-cancer-59334https://curecurrent.com/trials/claricore-optical-biopsy-system-used-in-trus-trans-rectal-ultrasound-guided-prostrate-biopsy-59335https://curecurrent.com/trials/seoul-national-university-prospectively-enrolled-registry-for-prostate-cancer-with-active-surveillance-59336https://curecurrent.com/trials/equivalence-of-intramuscular-im-versus-subcutaneous-sc-applications-of-long-acting-pamorelin-11-25-mg-59337https://curecurrent.com/trials/celecoxib-compared-with-no-treatment-before-surgery-in-treating-patients-with-localized-prostate-cancer-59338https://curecurrent.com/trials/phase-1-of-ec1169-in-patients-with-recurrent-mcrpc-59339https://curecurrent.com/trials/a-pilot-study-of-prostate-cancer-specific-anxiety-in-active-surveillance-59340https://curecurrent.com/trials/unilateral-nerve-sparing-cryoablation-for-low-risk-clinically-localized-unilateral-prostate-cancer-59341https://curecurrent.com/trials/less-to-hold-a-comparison-of-bladder-toxicities-side-effects-in-patients-undergoing-prostate-radiotherapy-between-patien-59342https://curecurrent.com/trials/the-effect-of-preemptive-analgesia-on-the-comfort-of-patient-and-doctor-in-cystoscopy-59343https://curecurrent.com/trials/bkm120-abiraterone-acetate-for-metastatic-crpc-59344https://curecurrent.com/trials/prospective-multicentre-cohort-study-prorepair-b-mcrpc-59345https://curecurrent.com/trials/a-study-to-evaluate-oral-vt-464-in-patients-with-castration-resistant-prostate-cancer-59346https://curecurrent.com/trials/a-study-to-evaluate-once-daily-oral-vt-464-in-patients-with-castration-resistant-prostate-cancer-59347https://curecurrent.com/trials/once-daily-oral-seviteronel-in-patients-with-castration-resistant-prostate-cancer-progressing-on-enzalutamide-or-abirate-59348https://curecurrent.com/trials/smarttarget-biopsy-59349https://curecurrent.com/trials/effect-of-weight-loss-on-prostate-cancer-pathology-59350https://curecurrent.com/trials/safety-and-efficacy-study-of-enzalutamide-versus-bicalutamide-in-men-with-prostate-cancer-59351https://curecurrent.com/trials/exercise-training-as-a-novel-primary-therapy-for-men-with-localised-prostate-cancer-59352https://curecurrent.com/trials/effect-of-triptorelin-decapeptyl-22-5-mg-on-two-biomarkers-in-patients-with-advanced-prostate-cancer-59353https://curecurrent.com/trials/clinical-trial-for-a-robotic-endomicroscopy-to-better-define-resection-strategies-applied-to-urology-surgery-59354https://curecurrent.com/trials/18f-fluciclovine-facbc-pet-ct-in-patients-with-rising-psa-after-initial-prostate-cancer-treatment-59355https://curecurrent.com/trials/treatment-patterns-among-patients-with-prostate-cancer-prior-to-diagnosis-of-a-castration-resistant-state-59356https://curecurrent.com/trials/biomarkers-in-bone-marrow-and-blood-samples-from-patients-with-prostate-cancer-treated-with-ketoconazole-59357https://curecurrent.com/trials/bicalutamide-and-raloxifene-hydrochloride-in-treating-patients-with-prostate-cancer-undergoing-surgery-59358https://curecurrent.com/trials/pilot-study-of-mobilization-and-treatment-of-disseminated-tumor-cells-in-men-with-metastatic-prostate-cancer-59359https://curecurrent.com/trials/degarelix-acetate-before-and-during-radiation-therapy-in-treating-patients-with-prostate-cancer-59360https://curecurrent.com/trials/focal-prostate-imaging-with-cle-and-oct-59361https://curecurrent.com/trials/detection-of-lymphnodes-using-icg-during-rarp-59362https://curecurrent.com/trials/ceus-targeted-biopsies-compared-to-mpmri-targeted-and-systematic-biopsies-for-the-detection-of-prostate-cancer-59363https://curecurrent.com/trials/multiparametric-ultrasound-imaging-in-prostate-cancer-59364https://curecurrent.com/trials/biodistribution-and-pharmacokinetic-study-of-18f-dcfbc-prostate-specific-membrane-antigen-based-pet-in-patients-with-adv-59365https://curecurrent.com/trials/efficacy-trial-of-the-implantation-of-mouse-renal-adenocarcinoma-macrobeads-in-subjects-with-castration-resistant-prosta-59366https://curecurrent.com/trials/compassionate-use-progressive-metastatic-castrate-resistant-prostate-cancer-monotherapy-treatment-with-trametinib-59367https://curecurrent.com/trials/assessment-of-a-new-fluorescence-imaging-technique-using-biopsies-from-prostate-resection-59368https://curecurrent.com/trials/bn83495-in-prostate-cancer-59369https://curecurrent.com/trials/robot-assisted-mri-guided-prostate-biopsy-59370https://curecurrent.com/trials/a-long-term-observational-study-cohort-in-patients-with-advanced-prostate-cancer-59371https://curecurrent.com/trials/a-multicenter-trial-enrolling-men-with-advanced-prostate-cancer-who-are-to-receive-combination-radiation-and-sipuleucel-59372https://curecurrent.com/trials/facbc-for-recurrent-prostate-cancer-59373https://curecurrent.com/trials/a-study-to-assess-ly01005-versus-goserelin-comparator-zoladex-in-patients-with-prostate-cancer-59374https://curecurrent.com/trials/a-study-of-prostate-and-pelvis-versus-prostate-alone-treatment-for-locally-advanced-prostate-cancer-59375https://curecurrent.com/trials/a-first-in-man-phase-i-evaluation-of-a-single-cycle-of-prohibitin-targeting-peptide-1-in-patients-with-metastatic-prosta-59376https://curecurrent.com/trials/functional-outcomes-and-qol-in-patients-with-high-versus-low-and-intermediate-risk-prostate-cancer-treated-by-rarp-59377https://curecurrent.com/trials/ed-recovery-in-men-age-65-treated-with-bilateral-nerve-sparing-robotic-assisted-prostatectomy-for-prostate-cancer-59378https://curecurrent.com/trials/the-biopsychosocial-burden-of-prostate-biopsy-59379https://curecurrent.com/trials/study-to-evaluate-the-presence-of-lower-urinary-tract-symptoms-luts-in-prostate-cancer-patients-scheduled-to-receive-lut-59380https://curecurrent.com/trials/quality-of-life-of-patients-with-locally-advanced-and-metastatic-prostate-cancer-59381https://curecurrent.com/trials/hypofractionated-focal-lesion-ablative-microboost-in-prostate-cancer-59382https://curecurrent.com/trials/rna-extraction-and-amplification-from-biopsy-specimens-in-subjects-with-metastatic-renal-cell-carcinoma-ags-nts-017-59383https://curecurrent.com/trials/retrospective-observational-study-investigating-fluciclovine-18f-facbc-59384https://curecurrent.com/trials/study-comparing-orteronel-plus-prednisone-in-participants-with-metastatic-castration-resistant-prostate-cancer-59385https://curecurrent.com/trials/surgery-combined-with-intensity-modulated-radiation-therapy-image-guided-radiation-therapy-imrt-igrt-in-locally-advanced-59386https://curecurrent.com/trials/phase-2-trial-of-carfilzomib-for-metastatic-castration-resistant-prostate-cancer-following-treatment-59387https://curecurrent.com/trials/prostate-cancer-patients-initiating-hormone-therapy-effect-of-exercise-on-cardiovascular-health-proscardio-59388https://curecurrent.com/trials/real-life-evaluation-of-lupron-in-the-management-of-prostate-cancer-a-canadian-post-marketing-observational-study-59389https://curecurrent.com/trials/a-study-of-vegf-tyrosine-kinase-inhibitor-pazopanib-in-men-with-high-risk-prostate-cancer-followed-by-radical-prostatect-59390https://curecurrent.com/trials/safety-and-efficacy-study-of-mdv3100-in-patients-with-castration-resistant-prostate-cancer-who-have-been-previously-trea-59391https://curecurrent.com/trials/safety-study-of-sorafenib-with-androgen-deprivation-and-radiotherapy-to-treat-prostate-cancer-59392https://curecurrent.com/trials/everolimus-in-treating-patients-with-newly-diagnosed-localized-prostate-cancer-59393https://curecurrent.com/trials/cabozantinib-in-men-with-castration-resistant-prostate-cancer-59394https://curecurrent.com/trials/a-pilot-study-to-enhance-f18-fdg-pet-imaging-of-prostate-cancers-with-the-metabolic-inhibitor-ranolazine-59395https://curecurrent.com/trials/vaccine-therapy-with-prostvac-tricom-and-flutamide-versus-flutamide-alone-to-treat-prostate-cancer-59396https://curecurrent.com/trials/prostatic-artery-embolization-for-obstructive-uropathy-due-to-prostate-cancer-59397https://curecurrent.com/trials/hormone-therapy-plus-chemotherapy-as-initial-treatment-for-local-failures-or-advanced-prostate-cancer-59398https://curecurrent.com/trials/hormonal-therapy-and-chemotherapy-followed-by-prostatectomy-in-patients-with-prostate-cancer-59399https://curecurrent.com/trials/mri-in-assessing-hypoxia-in-patients-with-localized-prostate-cancer-undergoing-stereotactic-body-radiation-therapy-59400https://curecurrent.com/trials/vitamin-d-and-soy-supplements-in-treating-patients-with-recurrent-prostate-cancer-59401https://curecurrent.com/trials/pilot-study-to-assess-the-safety-and-efficacy-of-bioprotect-balloon-in-prostate-cancer-subjects-59402https://curecurrent.com/trials/a-study-of-tak-385-in-hormone-treatment-na-ve-participants-with-prostate-cancer-59403https://curecurrent.com/trials/prognostic-value-of-androgen-receptor-expression-and-mutations-within-oncogenes-and-tumor-suppressor-genes-in-patients-t-59404https://curecurrent.com/trials/high-intensity-interval-training-hiit-for-patients-with-cancer-related-lymphedema-in-the-lower-limbs-59405https://curecurrent.com/trials/phase-i-study-of-weekly-intravenous-ps-341-bortezomib-plus-mitoxantrone-59406https://curecurrent.com/trials/preoperative-thalidomide-followed-by-radical-retropubic-prostatectomy-in-select-patients-with-locally-advanced-prostate-59407https://curecurrent.com/trials/phase-ii-study-of-dcvac-pca-after-primary-radiotherapy-for-patients-with-high-risk-localized-prostate-cancer-59408https://curecurrent.com/trials/a-study-of-abiraterone-acetate-plus-prednisone-in-asymptomatic-or-mildly-symptomatic-patients-with-metastatic-castration-59409https://curecurrent.com/trials/behavior-based-dietary-intervention-in-treating-patients-with-hormone-refractory-prostate-cancer-59410https://curecurrent.com/trials/drug-drug-interaction-study-to-assess-the-effect-of-darolutamide-on-the-pharmacokinetics-of-probe-substrates-of-cyp3a4-a-59411https://curecurrent.com/trials/bortezomib-with-or-without-hormone-therapy-in-treating-patients-with-relapsed-prostate-cancer-59412https://curecurrent.com/trials/chemotherapy-plus-hormone-therapy-versus-androgen-suppression-in-treating-patients-with-metastatic-or-unresectable-prost-59413https://curecurrent.com/trials/feasibility-study-of-prostate-tumor-localization-for-focal-cryoablation-of-prostate-carcinoma-59414https://curecurrent.com/trials/outcomes-of-mcrpc-patients-treated-with-ra-223-concomitant-with-abiraterone-or-enzalutamide-a-chart-review-study-59415https://curecurrent.com/trials/doxorubicin-and-strontium-89-with-or-without-celecoxib-in-treating-patients-with-progressive-androgen-independent-prosta-59416https://curecurrent.com/trials/phase-i-trial-of-fixed-dose-sti571-imatinib-mesylate-with-escalating-doses-of-docetaxel-in-patients-with-metastatic-andr-59417https://curecurrent.com/trials/study-of-paclitaxel-estramustine-phosphate-and-thalidomide-for-patients-with-metastatic-androgen-independent-prostate-ca-59418https://curecurrent.com/trials/pentafecta-outcomes-after-robot-assisted-laparoscopic-radical-prostatectomy-59419https://curecurrent.com/trials/psa-activated-psa-pah1-for-locally-recurrent-prostate-cancer-59420https://curecurrent.com/trials/phase-ii-sunitinib-prog-met-aipc-59421https://curecurrent.com/trials/choline-pet-ct-vs-dual-time-point-fdg-pet-ct-in-prostate-cancer-59422https://curecurrent.com/trials/vidaza-to-restore-hormone-thx-prostate-59423https://curecurrent.com/trials/a-study-of-ixabepilone-before-surgery-for-high-risk-localized-prostate-cancer-59424https://curecurrent.com/trials/chess-human-and-computer-mentors-for-prostate-cancer-patients-59425https://curecurrent.com/trials/a-study-of-sipuleucel-t-with-administration-of-enzalutamide-in-men-with-metastatic-castrate-resistant-prostate-cancer-59426https://curecurrent.com/trials/evaluate-recovery-of-testosterone-for-patients-using-eligard-59427https://curecurrent.com/trials/determine-effect-of-enzalutamide-mdv3100-on-the-androgen-signaling-pathway-in-correlation-with-the-anti-tumor-effects-of-59428https://curecurrent.com/trials/mri-with-c13-pilot-study-prostate-cancer-59429https://curecurrent.com/trials/effectiveness-and-safety-of-firmagon-in-androgen-ablative-therapy-of-advanced-hormone-dependent-prostate-carcinoma-in-ar-59430https://curecurrent.com/trials/study-of-enzalutamide-formerly-mdv3100-as-a-neoadjuvant-therapy-for-patients-undergoing-prostatectomy-for-localized-pros-59431https://curecurrent.com/trials/cognitive-remediation-therapy-crt-for-adults-treated-for-cancer-59432https://curecurrent.com/trials/assessing-the-potential-for-reduced-toxicity-using-focal-brachytherapy-in-early-stage-low-volume-prostate-cancer-59433https://curecurrent.com/trials/cardiotoxicity-profile-of-abiraterone-in-prostate-cancer-a-pharmacovigilance-study-59434https://curecurrent.com/trials/extension-study-to-evaluate-long-term-safety-of-denosumab-in-subjects-undergoing-adt-for-non-metastatic-prostate-cancer-59435https://curecurrent.com/trials/amg-162-in-the-treatment-of-bone-loss-in-subjects-undergoing-androgen-deprivation-therapy-for-non-metastatic-prostate-ca-59436https://curecurrent.com/trials/evaluation-of-gut-microbiome-in-patients-with-prostate-cancer-59437https://curecurrent.com/trials/study-on-prolonging-bone-metastasis-free-survival-in-men-with-hormone-refractory-prostate-cancer-59438https://curecurrent.com/trials/safety-study-of-a-shorter-hypofractionated-radiotherapy-for-the-prostate-bed-with-or-without-the-pelvic-lymph-nodes-59439https://curecurrent.com/trials/carbohydrate-restriction-and-prostate-cancer-growth-59440https://curecurrent.com/trials/vaccine-plus-booster-shots-in-men-with-prostate-cancer-undergoing-treatment-with-radical-prostatectomy-59441https://curecurrent.com/trials/a-phase-2-trial-of-bevacizumab-lenalidomide-docetaxel-and-prednisone-art-p-for-treatment-of-metastatic-castrate-resistan-59442https://curecurrent.com/trials/pilot-study-of-dribble-vaccine-for-prostate-cancer-patients-59443https://curecurrent.com/trials/hormone-therapy-with-or-without-definitive-radiotherapy-in-metastatic-prostate-cancer-59444https://curecurrent.com/trials/tupkrp-combined-with-mab-therapy-for-luts-pca-59445https://curecurrent.com/trials/azd2171-to-treat-prostate-cancer-59446https://curecurrent.com/trials/urothelium-tissue-engineering-using-biopsies-from-transurethral-resection-of-prostate-59447https://curecurrent.com/trials/selective-treatment-according-to-molecular-subtype-of-prostate-cancer-59448https://curecurrent.com/trials/satraplatin-and-prednisone-to-treat-prostate-cancer-59449https://curecurrent.com/trials/designing-a-digital-tool-to-support-healthy-lifestyle-in-men-with-prostate-cancer-59450https://curecurrent.com/trials/pet-acetate-for-castrate-resistant-prostate-cancer-on-chemotherapy-59451https://curecurrent.com/trials/a-study-to-test-if-enzalutamide-is-effective-and-safe-in-prostate-cancer-patients-who-have-never-had-hormone-therapy-59452https://curecurrent.com/trials/ethnographic-study-of-the-everyday-life-of-men-with-prostate-cancer-focusing-on-diet-activities-and-digital-behavior-59453https://curecurrent.com/trials/predictive-nomogram-of-crpc-59454https://curecurrent.com/trials/valproic-acid-in-treating-patients-with-progressive-non-metastatic-prostate-cancer-59455https://curecurrent.com/trials/active-surveillance-of-2-groups-of-patients-with-localized-prostate-cancer-59456https://curecurrent.com/trials/external-validation-of-prostate-mri-qcad-lyon-59457https://curecurrent.com/trials/preoperative-brimonidine-on-iop-of-patients-undergoing-ralp-59458https://curecurrent.com/trials/comparative-effectiveness-analysis-of-surgery-and-radiation-ceasar-for-localized-prostate-cancer-59459https://curecurrent.com/trials/radium-223-dichloride-asian-population-study-in-the-treatment-of-crpc-patients-with-bone-metastasis-59460https://curecurrent.com/trials/analysis-of-androgene-receptors-axis-and-dna-damage-repair-genes-in-patients-with-prostate-cancer-59461https://curecurrent.com/trials/treatment-patterns-in-castrate-resistant-prostate-cancer-patients-with-bone-metastases-in-a-medicare-population-59462https://curecurrent.com/trials/hsp90-inhibitor-sta-9090-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-previously-treated-with-59463https://curecurrent.com/trials/effect-of-anesthetic-method-on-optic-nerve-sheath-diameter-in-patients-undergoing-ralp-59464https://curecurrent.com/trials/castration-resistant-prostate-cancer-and-intra-prostatic-hormonal-status-59465https://curecurrent.com/trials/palliative-radiotherapy-to-dominant-symptomatic-lesion-in-patients-with-hormone-refractory-prostate-cancer-59466https://curecurrent.com/trials/tivantinib-in-treating-patients-with-metastatic-prostate-cancer-59467https://curecurrent.com/trials/phase-1a-1b-study-of-psa-il-2-gm-csf-vaccine-for-recurrent-prostate-cancer-in-hormone-naive-and-hormone-independent-pati-59468https://curecurrent.com/trials/comparison-of-a-novel-leuprolide-with-market-leuprolide-59469https://curecurrent.com/trials/prostate-radiotherapy-integrated-with-simultaneous-mri-the-prism-study-59470https://curecurrent.com/trials/machine-learning-optimization-for-prostate-brachytherapy-planning-59471https://curecurrent.com/trials/the-catch-prostate-cancer-trial-cabazitaxel-and-tasquinimod-in-men-with-prostate-cancer-59472https://curecurrent.com/trials/ketoconazole-hydrocortisone-dutasteride-and-lapatinib-khad-l-in-prostate-cancer-59473https://curecurrent.com/trials/quantitative-prostate-cancer-contrast-enhanced-ultrasound-59474https://curecurrent.com/trials/effects-of-an-interactive-ict-platform-for-assessment-and-management-of-symptoms-in-patients-treated-for-prostate-cancer-59475https://curecurrent.com/trials/study-of-denosumab-vs-zoledronic-acid-to-treat-bone-metastases-in-men-with-hormone-refractory-prostate-cancer-59476https://curecurrent.com/trials/clinical-application-of-68ga-psma-pet-in-prostate-cancer-59477https://curecurrent.com/trials/anti-ox40-cyclophosphamide-ctx-and-radiation-in-patients-with-progressive-metastatic-prostate-cancer-59478https://curecurrent.com/trials/evaluation-of-prostate-specific-membrane-antigen-psma-based-pet-imaging-of-primary-prostate-cancer-59479https://curecurrent.com/trials/gm-csf-and-thalidomide-in-treating-patients-undergoing-surgery-for-high-risk-prostate-cancer-59480https://curecurrent.com/trials/effect-of-lap-band-induced-weight-loss-on-serum-psa-levels-59481https://curecurrent.com/trials/phase-1-trial-of-the-mammalian-target-of-rapamycin-mtor-inhibitor-everolimus-plus-radiation-therapy-rt-for-salvage-treat-59482https://curecurrent.com/trials/endoscopic-evaluation-of-late-rectal-injury-following-cyberknife-radiosurgery-for-prostate-cancer-59483https://curecurrent.com/trials/accuracy-of-mpmri-and-mri-targeted-ultrasound-navigated-prostate-fusion-biopsy-in-detection-of-prostate-cancer-59484https://curecurrent.com/trials/sthlm3-prostate-cancer-diagnostic-trial-59485https://curecurrent.com/trials/evaluation-of-18f-dcfbc-psma-based-pet-imaging-for-detection-of-metastatic-prostate-cancer-59486https://curecurrent.com/trials/study-of-anatomic-nerve-sparing-radical-perineal-prostatectomy-59487https://curecurrent.com/trials/sbrt-for-oligometastatic-lymph-node-recurrence-in-prostate-cancer-a-single-institution-experience-59488https://curecurrent.com/trials/arsenic-trioxide-in-treating-patients-with-stage-iv-prostate-cancer-that-has-not-responded-to-previous-hormone-therapy-59489https://curecurrent.com/trials/prospective-validation-of-prostate-biomarkers-for-repeat-biopsy-59490https://curecurrent.com/trials/dynamic-focusing-evaluation-for-prostate-cancer-treatment-59491https://curecurrent.com/trials/functional-medical-imaging-quantization-in-prostate-cancer-59492https://curecurrent.com/trials/cardiovascular-risk-and-preventive-care-in-prostate-cancer-patients-receiving-radiation-and-hormone-therapy-59493https://curecurrent.com/trials/long-term-follow-up-of-a-cohort-of-children-with-tcf2-mutation-evolution-of-endocrine-and-renal-function-59494https://curecurrent.com/trials/soy-supplements-in-treating-patients-undergoing-surgery-for-localized-prostate-cancer-59495https://curecurrent.com/trials/the-safety-and-efficacy-of-18f-fluoromethylcholine-18f-fch-pet-ct-in-prostate-cancer-59496https://curecurrent.com/trials/docetaxel-and-prednisone-with-or-without-cediranib-in-treating-patients-with-metastatic-prostate-cancer-that-did-not-res-59497https://curecurrent.com/trials/maximal-suppression-of-the-androgen-axis-in-clinically-localized-prostate-cancer-59498https://curecurrent.com/trials/vigorous-or-moderate-exercise-in-enhancing-active-surveillance-in-patients-with-localized-prostate-cancer-59499https://curecurrent.com/trials/fastr-fairly-brief-androgen-suppression-and-stereotactic-radiotherapy-for-high-risk-prostate-cancer-59500https://curecurrent.com/trials/comparison-of-pet-with-68ga-psma-11-and-18f-fluorocholine-for-recurrence-in-men-with-prostate-cancer-59501https://curecurrent.com/trials/cediranib-maleate-with-or-without-dasatinib-in-patients-with-hrpc-resistant-to-treatment-with-docetaxel-59502https://curecurrent.com/trials/a-study-of-enzalutamide-in-combination-with-azd5363-in-patients-with-mcrpc-59503https://curecurrent.com/trials/effects-of-ias-in-men-with-localized-biochemical-relapsed-prostate-cancer-59504https://curecurrent.com/trials/exisulind-and-intermittent-androgen-suppression-adt-in-biochemical-relapsed-prostate-cancer-59505https://curecurrent.com/trials/18f-dihydro-testosterone-pet-and-mr-imaging-in-patients-with-localized-prostate-cancer-59506https://curecurrent.com/trials/a-study-of-oral-cfg920-in-patients-with-castration-resistant-prostate-cancer-59507https://curecurrent.com/trials/study-of-metformin-plus-oligomeric-procyanidin-complex-for-pharmacologic-manipulation-of-age-advanced-glycation-endprodu-59508https://curecurrent.com/trials/magnetic-resonance-guided-high-dose-brachytherapy-short-range-radiation-therapy-for-prostate-cancer-59509https://curecurrent.com/trials/fundaci-n-ivo-registry-for-patients-undergoing-sling-or-artificial-urinary-sphincter-after-prostate-cancer-treatment-59510https://curecurrent.com/trials/optical-tomography-in-prostate-cancer-59511https://curecurrent.com/trials/identification-of-prostate-cancer-genes-59512https://curecurrent.com/trials/bevacizumab-in-treating-patients-with-relapsed-prostate-cancer-that-did-not-respond-to-hormone-therapy-59513https://curecurrent.com/trials/radiotherapy-of-pelvic-lymph-nodes-in-high-risk-prostate-cancer-a-retrospective-analysis-59514https://curecurrent.com/trials/prospective-study-using-hybrid-pet-mri-to-evaluate-men-with-suspected-recurrence-following-treatment-for-prostate-cancer-59515https://curecurrent.com/trials/orteronel-maintenance-therapy-in-patients-with-mcrpc-previously-treated-with-novel-hormonal-agents-59516https://curecurrent.com/trials/pascual-prostate-assay-specific-clinical-utility-at-launch-study-59517https://curecurrent.com/trials/multicenter-study-comparing-taxotere-plus-curcumin-versus-taxotere-plus-placebo-combination-in-first-line-treatment-of-p-59518https://curecurrent.com/trials/prognostic-value-of-spect-ct-quantitative-indices-for-the-response-assessment-of-bone-metastatic-prostate-carcinoma-59519https://curecurrent.com/trials/imaging-of-prostate-cancer-using-two-dimensional-mr-spectroscopy-and-diffusion-tensor-imaging-59520https://curecurrent.com/trials/a-study-of-vismodegib-in-men-with-metastatic-crpc-with-accessible-metastatic-lesions-for-tumor-biopsy-59521https://curecurrent.com/trials/correlation-between-ixip-and-final-pathology-specimen-from-radical-prostatectomy-a-multicenter-prospective-trial-59522https://curecurrent.com/trials/study-with-imc-a12-cixutumumab-in-patients-who-have-not-previously-been-treated-with-chemotherapy-with-metastatic-prosta-59523https://curecurrent.com/trials/vitamin-d3-supplementation-in-participants-diagnosed-with-early-stage-prostate-cancer-who-decide-to-undergo-active-surve-59524https://curecurrent.com/trials/toxicity-pharmacokinetics-of-2-3-weekly-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-59525https://curecurrent.com/trials/allogeneic-human-bone-marrow-derived-mesenchymal-stem-cells-in-localized-prostate-cancer-59526https://curecurrent.com/trials/polyunsaturated-fatty-acids-in-treating-patients-with-prostate-cancer-undergoing-prostate-biopsy-and-or-surgery-59527https://curecurrent.com/trials/intensity-modulated-versus-interstitial-radiation-therapy-59528https://curecurrent.com/trials/ph-ib-iia-study-of-cabazitaxel-plus-bavituximab-in-castration-resistant-prostate-cancer-59529https://curecurrent.com/trials/dexamethasone-prior-to-re-treatment-with-enzalutamide-in-treating-patients-with-metastatic-hormone-resistant-prostate-ca-59530https://curecurrent.com/trials/intraprostatic-maximal-simultaneous-boost-59531https://curecurrent.com/trials/establishment-and-clinical-assessment-of-a-prostate-cancer-pca-risk-model-based-on-the-updated-circulating-tumor-cell-ct-59532https://curecurrent.com/trials/everolimus-in-castrated-resistant-prostate-cancer-crpc-patients-with-pi3k-akt-mtor-signaling-pathway-deficiency-59533https://curecurrent.com/trials/paricalcitol-in-treating-patients-with-advanced-prostate-cancer-and-bone-metastases-59534https://curecurrent.com/trials/ferumoxytol-enhanced-mri-for-the-detection-of-lymph-node-involvement-in-prostate-cancer-59535https://curecurrent.com/trials/cinacalcet-hydrochloride-in-treating-men-with-recurrent-prostate-cancer-59536https://curecurrent.com/trials/ciprofloxacin-compared-to-placebo-in-diagnosing-prostate-cancer-in-patients-undergoing-prostate-biopsy-59537https://curecurrent.com/trials/c-11-choline-pet-ct-scan-in-finding-metastases-in-patients-with-newly-diagnosed-high-risk-prostate-cancer-59538https://curecurrent.com/trials/omega-3-fatty-acids-in-treating-patients-with-advanced-prostate-cancer-59539https://curecurrent.com/trials/update-and-biodistribution-of-f-18-fmdht-pet-ct-in-normal-healthy-volunteers-and-patients-with-metastatic-prostate-cance-59540https://curecurrent.com/trials/microspheres-in-preventing-lymphatic-fluid-collection-after-surgery-in-patients-with-prostate-cancer-59541https://curecurrent.com/trials/single-agent-erlotinib-in-chemotherapy-naive-androgen-independent-prostate-cancer-59542https://curecurrent.com/trials/selinexor-in-treating-patients-with-abiraterone-acetate-and-or-enzalutamide-refractory-metastatic-castration-resistant-p-59543https://curecurrent.com/trials/docetaxel-estramustine-and-short-term-androgen-withdrawal-for-patients-with-a-rising-psa-after-local-treatment-59544https://curecurrent.com/trials/chemotherapy-after-prostatectomy-cap-for-high-risk-prostate-carcinoma-59545https://curecurrent.com/trials/evaluation-of-clarity-ultrasound-guidance-for-prostate-therapy-59546https://curecurrent.com/trials/radiation-therapy-with-or-without-antiandrogen-therapy-in-treating-patients-with-stage-i-or-stage-ii-prostate-cancer-59547https://curecurrent.com/trials/a-phase-ii-study-of-bay-43-9006-sorafenib-in-metastatic-androgen-independent-prostate-cancer-59548https://curecurrent.com/trials/magnetic-resonance-imaging-to-locate-and-characterize-prostate-cancer-59549https://curecurrent.com/trials/satraplatin-and-bevacizumab-in-treating-patients-with-metastatic-prostate-cancer-previously-treated-with-docetaxel-59550https://curecurrent.com/trials/intensity-modulated-radiation-therapy-prostate-cancer-59551https://curecurrent.com/trials/study-of-recurrent-prostate-cancer-with-rising-prostate-specific-antigen-psa-59552https://curecurrent.com/trials/pharmacodynamic-study-of-radium-223-in-men-with-bone-metastatic-castration-resistant-prostate-cancer-59553https://curecurrent.com/trials/atorvastatin-calcium-and-celecoxib-in-treating-patients-with-rising-psa-levels-after-local-therapy-for-prostate-cancer-59554https://curecurrent.com/trials/salvage-brachytherapy-and-interstitial-hyperthermia-for-locally-recurrent-prostate-carcinoma-following-radiation-therapy-59555https://curecurrent.com/trials/study-of-acai-juice-in-asymptomatic-or-minimally-symptomatic-prostate-cancer-patients-with-rising-psa-59556https://curecurrent.com/trials/pazopanib-docetaxel-prednisone-prostate-59557https://curecurrent.com/trials/metformin-docetaxel-association-in-metastatic-hormone-refractory-prostate-cancer-59558https://curecurrent.com/trials/a-bio-psychosocial-sexual-health-intervention-for-prostate-cancer-survivors-and-partners-a-feasibility-study-59559https://curecurrent.com/trials/study-of-abiraterone-acetate-and-prednisone-in-combination-with-cabazitaxel-in-patients-with-prostate-cancer-59560https://curecurrent.com/trials/geriatric-determinants-of-general-repercussion-of-radiotherapy-for-patient-over-75-years-with-prostate-cancer-59561https://curecurrent.com/trials/castration-compared-to-castration-plus-metformin-as-first-line-treatment-for-patients-with-advanced-prostate-cancer-59562https://curecurrent.com/trials/study-of-cabozantinib-xl184-versus-mitoxantrone-plus-prednisone-in-men-with-previously-treated-symptomatic-castration-re-59563https://curecurrent.com/trials/biomarkers-in-prostate-cancer-treated-with-srp-following-failure-of-fat-59564https://curecurrent.com/trials/thalidomide-for-the-treatment-of-hormone-dependent-prostate-cancer-59565https://curecurrent.com/trials/a-phase-i-ii-study-of-trc105-in-metastatic-castrate-resistant-prostate-cancer-crpc-59566https://curecurrent.com/trials/does-end-fire-technique-increase-detection-rate-of-prostate-cancer-at-first-re-biopsy-compared-to-side-fire-technique-59567https://curecurrent.com/trials/a-study-of-18f-alf-nota-neurotensin-pet-ct-for-imaging-prostate-cancer-59568https://curecurrent.com/trials/pilot-study-of-sbrt-and-cdx-1127-in-prostate-cancer-59569https://curecurrent.com/trials/radiation-therapy-with-or-without-goserelin-in-treating-patients-who-have-undergone-surgery-for-recurrent-or-refractory-59570https://curecurrent.com/trials/clinical-management-decisions-for-recurrent-prostate-cancer-patients-based-on-11c-acetate-pet-scan-59571https://curecurrent.com/trials/therapeutic-vaccine-plus-pd-1-knockout-in-prostate-cancer-treatment-59572https://curecurrent.com/trials/eflornithine-in-treating-patients-at-high-risk-of-developing-prostate-cancer-59573https://curecurrent.com/trials/prospective-study-comparing-extended-with-limited-pelvic-lymphadenectomy-in-intermediate-and-high-risk-prostate-cancer-p-59574https://curecurrent.com/trials/effect-of-yoga-counselling-on-quality-of-life-and-psychological-outcomes-of-prostate-cancer-patients-59575https://curecurrent.com/trials/psa-tool-for-prostate-cancer-screening-discussions-59576https://curecurrent.com/trials/telephone-counseling-men-with-prostate-cancer-partners-59577https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-tak-385-together-with-a-leuprorelin-observational-cohort-in-parti-59578https://curecurrent.com/trials/atorvastatin-before-prostatectomy-and-prostate-cancer-59579https://curecurrent.com/trials/a-pilot-study-of-physical-activity-for-improving-quality-of-life-in-prostate-cancer-patients-on-androgen-deprivation-the-59580https://curecurrent.com/trials/prostate-cancer-survivors-moving-toward-exercise-promote-trial-59581https://curecurrent.com/trials/exercise-prostate-cancer-and-circulating-tumour-cells-59582https://curecurrent.com/trials/effect-of-risedronate-on-bone-mass-in-older-men-receiving-neoadjuvant-therapy-for-prostate-cancer-59583https://curecurrent.com/trials/prostate-evaluation-for-clinically-important-disease-sampling-using-image-guidance-or-not-59584https://curecurrent.com/trials/efficacy-and-safety-study-of-etodolac-and-propranolol-in-patients-with-clinically-progressive-prostate-cancer-59585https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-kidney-cancer-59586https://curecurrent.com/trials/evaluation-of-the-metastasis-and-recurrence-of-prostate-cancer-59587https://curecurrent.com/trials/focal-prostate-radiofrequency-ablation-59588https://curecurrent.com/trials/japanese-bay88-8223-monotherapy-phase-ii-study-59589https://curecurrent.com/trials/using-fiducial-markers-to-aid-in-prostate-cancer-radiation-treatment-59590https://curecurrent.com/trials/focal-therapy-for-prostate-cancer-using-hifu-59591https://curecurrent.com/trials/docetaxel-thalidomide-prednisone-and-bevacizumab-to-treat-metastatic-prostate-cancer-59592https://curecurrent.com/trials/prospective-evaluation-of-stereotactic-body-radiotherapy-for-metastatic-prostate-cancer-59593https://curecurrent.com/trials/azd0530-in-treating-patients-with-prostate-cancer-that-did-not-respond-to-hormone-therapy-59594https://curecurrent.com/trials/a-study-of-enzalutamide-re-treatment-in-metastatic-castration-resistant-prostate-cancer-after-docetaxel-and-or-cabazitax-59595https://curecurrent.com/trials/a-study-of-a-new-local-anesthesia-method-for-transperineal-prostate-biopsy-59596https://curecurrent.com/trials/niclosamide-and-enzalutamide-in-treating-patients-with-castration-resistant-metastatic-prostate-cancer-59597https://curecurrent.com/trials/prostate-magnetic-resonance-imaging-in-patient-with-previous-negative-biopsies-59598https://curecurrent.com/trials/mri-and-biomarkers-in-prostate-cancer-59599https://curecurrent.com/trials/a-phase-ii-trial-of-high-dose-rate-brachytherapy-as-monotherapy-in-low-and-intermediate-risk-prostate-cancer-59600https://curecurrent.com/trials/the-efficacy-and-safety-of-composite-steep-pulse-treatment-apparatus-used-in-prostate-cancer-focal-therapy-59601https://curecurrent.com/trials/perineal-versus-rectal-approach-for-prostate-biopsy-to-prevent-iatrogenic-infections-59602https://curecurrent.com/trials/epirubicin-and-docetaxel-in-treating-patients-with-metastatic-prostate-cancer-59603https://curecurrent.com/trials/effect-of-peep-on-arterial-oxygen-partial-pressure-in-elderly-patients-with-lithotomy-position-using-lma-supreme-59604https://curecurrent.com/trials/assessing-circulating-tumor-cell-as-a-biomarker-for-prostate-cancer-detection-in-patients-with-gray-zone-psa-level-59605https://curecurrent.com/trials/study-to-evaluate-safety-and-effectiveness-of-lenalidomide-in-combination-with-docetaxel-and-prednisone-for-patients-wit-59606https://curecurrent.com/trials/mln8237-for-a-subject-with-adenocarcinoma-of-the-prostate-59607https://curecurrent.com/trials/positive-end-expiratory-pressure-induced-increase-in-central-venous-pressure-as-a-predictor-of-fluid-responsiveness-in-r-59608https://curecurrent.com/trials/the-accuracy-of-modified-ttmb-in-the-spatial-distribution-of-prostate-cancer-59609https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-organ-confined-prostate-cancer-59610https://curecurrent.com/trials/effect-of-sulforaphane-on-prostate-cancer-prevention-59611https://curecurrent.com/trials/learning-curve-of-digital-rectal-examination-for-prostate-cancer-among-internship-59612https://curecurrent.com/trials/a-multicenter-phase-i-ii-trial-of-abiraterone-acetate-bez235-in-metastatic-castration-resistant-prostate-cancer-59613https://curecurrent.com/trials/pain-comparison-whit-visual-analog-scale-eva-between-four-analgesic-methods-during-trans-rectal-prostatic-biopsy-59614https://curecurrent.com/trials/re-treatment-safety-of-radium-223-dichloride-in-castration-resistant-prostate-cancer-with-bone-metastases-59615https://curecurrent.com/trials/strategies-to-improve-bone-health-in-men-on-adt-59616https://curecurrent.com/trials/a-safety-study-of-abiraterone-acetate-administered-in-combination-with-docetaxel-in-patients-with-metastatic-castration-59617https://curecurrent.com/trials/68ga-psma-pet-ct-or-pet-mri-in-evaluating-patients-with-recurrent-prostate-cancer-59618https://curecurrent.com/trials/study-in-japan-and-ex-japan-to-characterize-the-pharmacokinetic-and-pharmacodynamic-response-to-orteronel-tak-700-in-che-59619https://curecurrent.com/trials/safety-and-efficacy-trial-of-a-rnactive-derived-prostate-cancer-vaccine-in-hormone-refractory-disease-59620https://curecurrent.com/trials/diindolylmethane-in-treating-patients-with-stage-i-or-stage-ii-prostate-cancer-undergoing-radical-prostatectomy-59621https://curecurrent.com/trials/abiraterone-acetate-combined-with-dutasteride-for-metastatic-castrate-resistant-prostate-cancer-59622https://curecurrent.com/trials/study-of-cabozantinib-xl184-versus-prednisone-in-men-with-metastatic-castration-resistant-prostate-cancer-previously-tre-59623https://curecurrent.com/trials/neoadjuvant-dasatinib-plus-lhrh-analogue-therapy-in-high-risk-localized-prostate-cancer-59624https://curecurrent.com/trials/mr-guided-laser-interstitial-thermal-therapy-in-treating-patients-with-prostate-cancer-59625https://curecurrent.com/trials/optimized-2d-rt-for-prostate-cancer-59626https://curecurrent.com/trials/effectiveness-of-community-based-football-in-prostate-cancer-59627https://curecurrent.com/trials/efficacy-and-safety-study-of-le-dt-to-treat-metastatic-castrate-resistant-prostate-cancer-59628https://curecurrent.com/trials/adaptation-of-the-american-cancer-society-acs-early-detection-of-prostate-cancer-patient-decision-aid-for-spanish-speaki-59629https://curecurrent.com/trials/tecemotide-l-blp25-in-prostate-cancer-59630https://curecurrent.com/trials/mri-targeted-focal-laser-thermal-therapy-of-prostate-cancer-59631https://curecurrent.com/trials/safety-preliminary-efficacy-and-pharmacokinetics-of-asn001-in-metastatic-castrate-resistant-prostate-cancer-59632https://curecurrent.com/trials/couples-therapy-to-enhance-intimacy-between-patients-with-advanced-or-recurrent-prostate-cancer-and-their-partners-59633https://curecurrent.com/trials/prevention-of-prostate-cancer-with-dutasteride-in-case-of-high-grade-pin-neoplasia-59634https://curecurrent.com/trials/combined-intensified-and-modulated-adjuvant-therapy-in-prostate-carcinoma-59635https://curecurrent.com/trials/correlation-between-suv-on-68ga-hbed-cc-psma-and-gleason-score-in-prostate-cancer-59636https://curecurrent.com/trials/hypo-fractionated-postoperative-imrt-in-prostate-cancer-59637https://curecurrent.com/trials/vessel-sparing-prostate-radiation-therapy-59638https://curecurrent.com/trials/safety-and-anti-tumor-study-of-oral-epi-506-for-patients-with-metastatic-castration-resistant-prostate-cancer-59639https://curecurrent.com/trials/evaluation-of-focal-treatments-of-localized-prostate-cancers-with-high-intensity-focused-ultrasound-using-the-focal-one-59640https://curecurrent.com/trials/physicians-health-study-ii-59641https://curecurrent.com/trials/phase-ii-randomized-trial-of-radiation-therapy-in-oligometastatic-mcrpc-prostate-cancer-arto-59642https://curecurrent.com/trials/effect-of-tyg-index-on-outcomes-of-radical-prostatectomy-59643https://curecurrent.com/trials/bicalutamide-and-goserelin-or-leuprolide-acetate-with-or-without-cixutumumab-in-treating-patients-with-newly-diagnosed-m-59644https://curecurrent.com/trials/evaluation-of-the-potential-association-between-5-reductase-inhibitors-prescription-and-occurrence-of-high-grade-prostat-59645https://curecurrent.com/trials/performance-evaluation-of-the-ams-continuum-device-59646https://curecurrent.com/trials/individual-phenotype-analysis-in-patients-with-castration-resistant-prostate-cancer-with-cellsearch-and-flow-cytometry-59647https://curecurrent.com/trials/prostate-evaluation-for-clinically-important-disease-mri-vs-standard-evaluation-procedures-59648https://curecurrent.com/trials/prostate-impendance-test-project-59649https://curecurrent.com/trials/an-exercise-intervention-for-prostate-cancer-patients-receiving-androgen-deprivation-therapy-59650https://curecurrent.com/trials/tadalafil-in-preventing-erectile-dysfunction-in-patients-with-prostate-cancer-treated-with-radiation-therapy-59651https://curecurrent.com/trials/study-of-antioxidants-on-mri-detectable-early-stage-prostate-cancer-among-men-on-active-surveillance-59652https://curecurrent.com/trials/utilizing-a-genomic-sig-for-brcaness-to-eval-the-efficacy-of-satraplatin-in-men-with-met-castration-resistant-prostate-c-59653https://curecurrent.com/trials/study-of-ruxolitinib-incb018424-administered-orally-to-patients-with-androgen-independent-metastatic-prostate-cancer-59654https://curecurrent.com/trials/hypofractionated-whole-pelvic-radiotherapy-of-the-prostate-59655https://curecurrent.com/trials/incidence-of-second-primary-malignancies-in-prostate-cancer-patients-with-bone-metastases-an-observational-retrospective-59656https://curecurrent.com/trials/spanish-urological-association-registry-of-patients-on-active-surveillance-59657https://curecurrent.com/trials/intra-operative-neuromodulation-of-the-pelvic-plexus-59658https://curecurrent.com/trials/safety-and-efficacy-studies-of-panobinostat-and-bicalutamide-in-patients-with-recurrent-prostate-cancer-after-castration-59659https://curecurrent.com/trials/benefits-of-an-intervention-combining-hypnosis-and-self-care-for-prostate-cancer-patients-59660https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-stage-iii-or-stage-iv-prostate-cancer-59661https://curecurrent.com/trials/prostate-cancer-imaging-treatment-and-toxicity-procitt-59662https://curecurrent.com/trials/open-label-phase-two-trial-of-radium-ra-223-dichloride-with-concurrent-administration-of-abiraterone-acetate-plus-predni-59663https://curecurrent.com/trials/personal-patient-profile-prostate-p3p-ii-effectiveness-implementation-trial-in-diverse-health-care-networks-59664https://curecurrent.com/trials/prostate-conformal-cryotherapy-59665https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-refractory-stage-iv-prostate-cancer-59666https://curecurrent.com/trials/a-pre-market-study-of-the-american-medical-systems-ams-transobturator-male-sling-system-for-the-treatment-of-male-stress-59667https://curecurrent.com/trials/comparing-transperineal-to-transrectal-mri-us-fusion-prostate-biopsy-59668https://curecurrent.com/trials/provenge-treatment-and-early-cancer-treatment-59669https://curecurrent.com/trials/clinical-trial-to-examine-individual-pain-tolerance-in-the-use-of-two-anesthetic-techniques-to-perform-saturation-prosta-59670https://curecurrent.com/trials/phase-1-dose-escalation-study-of-bay-1841788-in-japanese-metastatic-castration-resistant-prostate-cancer-mcrpc-subjects-59671https://curecurrent.com/trials/treatment-patterns-in-metastatic-prostate-cancer-59672https://curecurrent.com/trials/health-related-quality-of-life-in-gay-men-with-localized-prostate-cancer-59673https://curecurrent.com/trials/prostate-cancer-symptom-management-for-low-literacy-men-59674https://curecurrent.com/trials/psychosocial-and-patient-education-needs-of-prostate-cancer-patients-selecting-watchful-waiting-59675https://curecurrent.com/trials/a-phase-ii-trial-of-mln8237-in-patients-with-metastatic-castrate-resistant-and-neuroendocrine-prostate-cancer-59676https://curecurrent.com/trials/lycopene-or-green-tea-for-men-at-risk-of-prostate-cancer-59677https://curecurrent.com/trials/erectile-recovery-after-robotic-assisted-laparoscopic-prostatectomy-59678https://curecurrent.com/trials/second-primary-cancers-in-patients-with-castration-resistant-prostate-cancer-59679https://curecurrent.com/trials/solifenacin-succinate-for-treatment-of-urinary-toxicity-occurring-during-radiotherapy-of-prostatic-cancer-59680https://curecurrent.com/trials/enzalutamide-and-external-beam-hypofractionated-radiotherapy-for-intermediate-risk-localized-prostate-cancer-59681https://curecurrent.com/trials/impact-of-local-anesthesia-type-on-cancer-detection-rate-in-transrectal-ultrasound-guided-prostate-biopsy-59682https://curecurrent.com/trials/177lu-eb-psma617-in-patients-with-metastatic-castration-resistant-prostate-cancer-59683https://curecurrent.com/trials/c-arm-cone-beam-ct-in-prostate-brachytherapy-59684https://curecurrent.com/trials/durvalumab-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-59685https://curecurrent.com/trials/docetaxel-and-lycopene-in-metastatic-prostate-cancer-59686https://curecurrent.com/trials/metformin-hydrochloride-in-treating-patients-with-prostate-cancer-undergoing-surgery-59687https://curecurrent.com/trials/bicalutamide-with-or-without-everolimus-in-treating-patients-with-recurrent-or-metastatic-prostate-cancer-59688https://curecurrent.com/trials/devel-and-eval-of-an-active-surveillance-decision-aid-for-men-with-low-or-intermediate-grade-prostate-cancer-59689https://curecurrent.com/trials/does-bloody-urine-predict-urethrovesical-anastomosis-leakage-after-radical-prostatectomy-59690https://curecurrent.com/trials/abiraterone-post-ketoconazole-for-prostate-cancer-59691https://curecurrent.com/trials/pre-operative-pet-mr-of-high-risk-prostate-cancer-patients-for-assessment-of-cancer-aggressiveness-and-lymph-node-status-59692https://curecurrent.com/trials/a-study-with-bibf-1120-in-patients-with-hormone-refractory-prostate-cancer-59693https://curecurrent.com/trials/trial-to-evaluate-safety-and-immunogenicity-of-ino-5150-alone-or-with-ino-9012-in-men-with-prostate-cancer-59694https://curecurrent.com/trials/prostatectomy-prospective-database-59695https://curecurrent.com/trials/black-cohosh-for-host-flashes-due-to-androgen-deprivation-therapy-59696https://curecurrent.com/trials/calcium-41-41ca-chloride-aqueous-solution-in-diagnosing-patients-with-prostate-cancer-and-bone-metastasis-59697https://curecurrent.com/trials/metformin-for-rising-psa-remote-trial-59698https://curecurrent.com/trials/mri-before-biopsy-in-diagnosing-patients-with-prostate-cancer-59699https://curecurrent.com/trials/cabazitaxel-with-or-without-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer-progressed-durin-59700https://curecurrent.com/trials/feasibility-of-a-consumer-based-accelerometer-in-monitoring-outpatient-physical-activity-a-study-in-patients-with-cancer-59701https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-metastatic-prostate-cancer-59702https://curecurrent.com/trials/trial-of-cabozantinib-xl184-in-castrate-resistant-prostate-cancer-metastatic-to-bone-59703https://curecurrent.com/trials/docetaxel-radiation-therapy-and-prednisone-in-treating-patients-who-have-undergone-surgery-for-prostate-cancer-59704https://curecurrent.com/trials/rad001-and-bicalutamide-for-androgen-independent-prostate-cancer-59705https://curecurrent.com/trials/cabazitaxel-vs-abiraterone-or-enzalutamide-in-patients-with-poor-prognosis-metastatic-castration-resistant-prostate-canc-59706https://curecurrent.com/trials/real-time-mv-kv-image-guided-radiation-therapy-59707https://curecurrent.com/trials/bicalutamide-and-ro4929097-in-treating-patients-with-previously-treated-prostate-cancer-59708https://curecurrent.com/trials/evaluation-of-diagnostic-value-of-3-t-magnetic-resonance-imaging-mri-in-suspected-prostate-cancer-59709https://curecurrent.com/trials/docetaxel-versus-abiraterone-as-first-line-treatment-in-mcrpc-patients-with-intraductal-carcinoma-of-the-prostate-59710https://curecurrent.com/trials/phase-ii-gm-csf-plus-mitoxantrone-in-hormone-refractory-prostate-cancer-59711https://curecurrent.com/trials/mri-guided-biopsy-of-recurrent-prostate-cancer-after-radiotherapy-59712https://curecurrent.com/trials/zoledronate-in-preventing-osteoporosis-and-bone-fractures-in-patients-with-locally-advanced-nonmetastatic-prostate-cance-59713https://curecurrent.com/trials/real-life-data-of-cardiovascular-events-occuring-during-degarelix-therapy-for-prostate-cancer-59714https://curecurrent.com/trials/thalidomide-and-doxil-in-patients-with-androgen-independent-prostate-cancer-aipc-59715https://curecurrent.com/trials/sorafenib-tosylate-and-gene-expression-analysis-in-patients-undergoing-surgery-for-high-risk-localized-prostate-cancer-59716https://curecurrent.com/trials/outcomes-from-a-rct-comparing-preventive-versus-delayed-ligation-of-dvc-during-robot-assisted-radical-prostatectomy-59717https://curecurrent.com/trials/a-study-combining-abt-888-oral-parp-inhibitor-with-temozolomide-in-patients-with-metastatic-prostate-cancer-59718https://curecurrent.com/trials/calcitriol-and-dexamethasone-in-treating-patients-with-prostate-cancer-that-did-not-respond-to-hormone-therapy-59719https://curecurrent.com/trials/early-switch-from-first-line-docetaxel-prednisone-to-cabazitaxel-prednisone-and-the-opposite-sequence-exploring-molecula-59720https://curecurrent.com/trials/a-study-of-zen003694-in-patients-with-metastatic-castration-resistant-prostate-cancer-59721https://curecurrent.com/trials/place-of-68ga-psma-11-pet-ct-in-the-therapeutic-decision-at-the-end-of-the-initial-staging-for-high-risk-prostate-cancer-59722https://curecurrent.com/trials/dose-finding-study-of-bkm-120-in-combination-with-lh-rh-agonists-and-bicalutamide-in-men-with-non-castrate-metastatic-pr-59723https://curecurrent.com/trials/respiratory-measurement-using-infrared-camera-and-respiratory-volume-monitor-exspiron-1xi-for-sedation-in-patients-under-59724https://curecurrent.com/trials/carbon-11-labeled-sarcosine-in-prostate-cancer-59725https://curecurrent.com/trials/french-validation-of-the-memorial-anxiety-scale-for-patients-with-prostate-cancer-59726https://curecurrent.com/trials/a-phase-1-trial-for-evaluation-of-the-safety-pharmacokinetics-and-18f-radiation-dosimetry-of-ctt1057-59727https://curecurrent.com/trials/f-18-sodium-fluoride-in-prostate-cancer-59728https://curecurrent.com/trials/patient-educational-materials-for-prostate-cancer-screening-59729https://curecurrent.com/trials/treating-patients-with-metastatic-prostate-cancer-not-responding-to-hormone-and-chemotherapy-59730https://curecurrent.com/trials/docetaxel-followed-by-provenge-in-metastatic-prostate-cancer-59731https://curecurrent.com/trials/provenge-followed-by-docetaxel-in-castration-resistant-prostate-cancer-59732https://curecurrent.com/trials/immunotherapy-study-of-evofosfamide-in-combination-with-ipilimumab-59733https://curecurrent.com/trials/protection-of-rectum-from-high-radiation-doses-using-a-spacer-59734https://curecurrent.com/trials/advanced-pelvic-floor-training-program-for-prostate-cancer-surgery-59735https://curecurrent.com/trials/sequential-vaccinations-in-prostate-cancer-patients-59736https://curecurrent.com/trials/pharmacokinetics-of-degarelix-in-chinese-patients-with-prostate-cancer-59737https://curecurrent.com/trials/novel-window-of-opportunity-trial-to-evaluate-the-impact-of-statins-to-oppose-prostate-cancer-59738https://curecurrent.com/trials/effect-of-anesthesia-on-optic-nerve-sheath-diameter-in-patients-undergoing-robot-assisted-laparoscopic-prostatectomy-59739https://curecurrent.com/trials/study-of-antioxidants-on-prostate-tumors-in-men-undergoing-radical-prostatectomy-for-prostate-cancer-59740https://curecurrent.com/trials/reducing-sedentary-behavior-among-prostate-cancer-survivors-on-androgen-deprivation-therapy-59741https://curecurrent.com/trials/hypofractionated-stereotactic-body-radiation-therapy-sbrt-59742https://curecurrent.com/trials/a-phase-2-study-to-evaluate-safety-and-efficacy-of-abiraterone-in-participants-with-prostate-cancer-59743https://curecurrent.com/trials/phase-1-study-of-abiraterone-acetate-in-castration-resistant-prostate-cancer-59744https://curecurrent.com/trials/a-pilot-trial-of-sonoelastography-for-planning-tumor-targeted-prostate-biopsy-59745https://curecurrent.com/trials/internal-radiation-therapy-in-treating-patients-with-prostate-cancer-59746https://curecurrent.com/trials/study-of-sildenafil-citrate-during-and-after-radiotherapy-hormone-therapy-for-erectile-function-versus-radiotherapy-horm-59747https://curecurrent.com/trials/computer-based-behavior-change-guide-in-increasing-physical-activity-in-patients-with-prostate-cancer-who-have-received-59748https://curecurrent.com/trials/mri-based-active-surveillance-to-avoid-the-risks-of-serial-biopsies-in-men-with-low-risk-prostate-ca-59749https://curecurrent.com/trials/the-effect-of-adt-on-psma-pet-59750https://curecurrent.com/trials/prostate-cancer-screening-among-men-with-high-risk-genetic-predisposition-59751https://curecurrent.com/trials/a-two-dose-level-clinical-trial-of-itraconazole-in-patients-with-metastatic-prostate-cancer-who-have-had-disease-progres-59752https://curecurrent.com/trials/effect-of-soy-on-cognition-and-hot-flashes-in-men-with-prostate-cancer-undergoing-testosterone-suppression-therapy-59753https://curecurrent.com/trials/choline-pet-ct-vs-meaib-pet-ct-in-prostate-cancer-59754https://curecurrent.com/trials/adoption-acceptability-and-effectiveness-of-a-mobile-health-app-for-personalised-prostate-cancer-survivorship-care-59755https://curecurrent.com/trials/radar-trial-randomised-androgen-deprivation-and-radiotherapy-59756https://curecurrent.com/trials/nanocurcumin-for-prostate-cancer-patients-undergoing-radiotherapy-rt-59757https://curecurrent.com/trials/use-of-pet-mri-tracer-to-further-understanding-of-prostate-cancer-development-59758https://curecurrent.com/trials/mri-targeted-focal-ablation-of-the-prostate-in-men-with-prostate-cancer-59759https://curecurrent.com/trials/prospective-cohort-study-of-the-ability-of-mri-dti-to-diagnose-prostate-cancer-59760https://curecurrent.com/trials/integrated-18f-labelled-psma-project-59761https://curecurrent.com/trials/vitamin-d-supplementation-in-veterans-with-early-stage-prostate-cancer-59762https://curecurrent.com/trials/prostate-nutrition-and-exercise-study-pronest-59763https://curecurrent.com/trials/relationship-between-mitochondrial-dysfunction-and-fatique-in-cancer-patients-following-external-beam-radiation-therapy-59764https://curecurrent.com/trials/salvage-radiation-therapy-and-taxotere-for-psa-failure-after-radical-prostatectomy-59765https://curecurrent.com/trials/androgen-deprivation-therapy-and-vorinostat-followed-by-radical-prostatectomy-in-treating-patients-with-localized-prosta-59766https://curecurrent.com/trials/3-month-finasteride-challenge-test-can-significantly-improve-the-performance-of-screening-for-prostate-cancer-59767https://curecurrent.com/trials/treatment-with-radiolabeled-monoclonal-antibody-huj591-gs-177lu-j591-in-patients-with-metastatic-prostate-cancer-59768https://curecurrent.com/trials/predictors-of-normal-tissue-response-from-the-microenvironment-in-radiotherapy-for-prostate-and-head-and-neck-cancer-59769https://curecurrent.com/trials/safety-study-of-combination-of-hormone-therapy-paclitaxel-and-radiation-therapy-to-treat-prostate-cancer-59770https://curecurrent.com/trials/smart-after-care-in-patients-with-prostate-cancer-59771https://curecurrent.com/trials/dynamics-of-androgen-receptor-genomics-and-transcriptomics-after-neoadjuvant-androgen-ablation-59772https://curecurrent.com/trials/bone-health-observational-study-59773https://curecurrent.com/trials/application-of-megavoltage-imaging-to-reduce-artifact-after-seed-implants-59774https://curecurrent.com/trials/the-potential-use-of-bold-mri-as-a-noninvasive-measure-of-tumor-hypoxia-in-prostate-cancer-59775https://curecurrent.com/trials/a-multicenter-randomized-double-blind-placebo-controlled-pilot-study-of-safety-pharmacodynamics-and-efficacy-of-differen-59776https://curecurrent.com/trials/safety-and-tolerability-clinical-trial-of-different-doses-of-the-immunotherapeutic-drug-mobilan-m-vm3-and-placebo-in-pat-59777https://curecurrent.com/trials/docetaxel-and-prednisone-with-or-without-vaccine-therapy-in-treating-patients-with-metastatic-hormone-resistant-prostate-59778https://curecurrent.com/trials/prostate-cancer-localized-adenocarcinoma-proton-therapy-59779https://curecurrent.com/trials/robotic-assisted-laparoscopic-prostatectomy-with-or-without-pelvic-drain-placement-in-reducing-adverse-events-after-surg-59780https://curecurrent.com/trials/efficacy-of-prostatic-artery-embolization-pae-in-patients-with-severe-benign-prostatic-hyperplasia-bph-59781https://curecurrent.com/trials/the-effect-of-zoledronic-acid-on-bone-loss-in-prostate-cancer-patients-undergoing-androgen-deprivation-therapy-59782https://curecurrent.com/trials/prostvac-vf-tricom-vaccine-for-the-treatment-of-metastatic-prostate-cancer-after-failing-hormone-therapy-59783https://curecurrent.com/trials/proton-beam-radiation-therapy-for-early-stage-adenocarcinoma-of-the-prostate-59784https://curecurrent.com/trials/registry-to-measure-the-impact-of-adding-genomic-testing-59785https://curecurrent.com/trials/open-registry-measuring-impact-of-genomic-testing-on-treatment-decision-after-biopsy-in-newly-diagnosed-prostate-cancer-59786https://curecurrent.com/trials/orteronel-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-59787https://curecurrent.com/trials/prostate-cancer-utilities-and-cost-effectiveness-analysis-59788https://curecurrent.com/trials/robotic-laparoscopic-radical-prostatectomy-59789https://curecurrent.com/trials/prostate-cancer-treatment-following-radiation-failure-with-high-intensity-focused-ultrasound-hifu-59790https://curecurrent.com/trials/hypo-fractionated-radiation-therapy-for-localized-prostate-cancer-59791https://curecurrent.com/trials/effect-of-tachosil-on-incidence-of-symptomatic-and-radiographic-lymphoceles-after-extended-pelvic-lymph-node-dissection-59792https://curecurrent.com/trials/hypofractionated-intensity-modulated-and-image-guided-radiotherapy-for-localized-prostate-cancer-59793https://curecurrent.com/trials/effect-of-mannitol-on-optic-nerve-sheath-diameter-in-patients-undergoing-robotic-prostatectomy-59794https://curecurrent.com/trials/sipuleucel-t-and-ipilimumab-for-advanced-prostate-cancer-59795https://curecurrent.com/trials/prehabilitation-for-prostate-cancer-surgery-59796https://curecurrent.com/trials/study-of-granulocyte-macrophage-colony-stimulating-factor-gm-csf-for-patients-with-rising-prostate-specific-antigen-psa-59797https://curecurrent.com/trials/navigator-guided-e-psychoeducational-intervention-59798https://curecurrent.com/trials/prospective-evaluation-of-68ga-psma-pet-ct-for-recurrence-detection-of-prostate-cancer-and-its-impact-on-patient-managem-59799https://curecurrent.com/trials/prostate-delineation-high-quality-volume-ct-59800https://curecurrent.com/trials/sthlm3-mr-comparing-standard-with-targeted-prostate-biopsies-59801https://curecurrent.com/trials/peptide-specific-vaccination-in-hla-a-02-positive-patients-with-biochemical-recurrence-after-radical-prostatectomy-59802https://curecurrent.com/trials/chemotherapy-response-monitoring-with-18f-choline-pet-ct-in-hormone-refractory-prostate-cancer-59803https://curecurrent.com/trials/focal-brachytherapy-in-patients-with-selected-low-risk-prostate-cancer-a-phase-ii-trial-59804https://curecurrent.com/trials/prostatic-artery-embolization-before-radical-prostatectomy-in-prostate-cancer-a-proof-of-concept-study-59805https://curecurrent.com/trials/a-study-of-imatinib-and-docetaxel-in-prostate-cancer-59806https://curecurrent.com/trials/plasma-and-urine-samples-from-patients-with-hormone-refractory-prostate-cancer-enrolled-on-clinical-trials-calgb-9480-or-59807https://curecurrent.com/trials/vascular-changes-of-patients-undergoing-laparoscopic-radical-prostatectomy-59808https://curecurrent.com/trials/use-of-non-invasive-4d-ultrasound-clarity-system-in-prostate-imrt-rapidarc-therapy-59809https://curecurrent.com/trials/a-study-to-determine-the-safety-tolerability-pharmacokinetics-and-dynamic-effects-of-different-doses-of-the-study-drug-e-59810https://curecurrent.com/trials/profit-prostate-fractionated-irradiation-trial-59811https://curecurrent.com/trials/transurethral-ultrasonic-imaging-for-detection-and-classification-of-prostate-cancer-59812https://curecurrent.com/trials/culture-and-characterization-of-circulating-tumor-cells-ctc-in-melanoma-and-other-cancers-59813https://curecurrent.com/trials/samarium-sm-153-lexidronam-pentasodium-and-3-dimensional-conformal-radiation-therapy-or-intensity-modulated-radiation-th-59814https://curecurrent.com/trials/cyberknife-radiosurgery-for-localized-prostatic-carcinoma-59815https://curecurrent.com/trials/accuracy-of-lymph-node-imaging-in-prostate-cancer-psma-pet-ct-and-nano-mri-59816https://curecurrent.com/trials/cyberknife-radiosurgery-for-locally-recurrent-prostate-ca-59817https://curecurrent.com/trials/phase-i-cabazitaxel-mitoxantrone-and-prednisone-metastatic-castration-resistant-prostate-cancer-59818https://curecurrent.com/trials/pet-mr-assessment-of-sipuleucel-t-treatment-for-metastatic-castration-resistant-prostate-cancer-59819https://curecurrent.com/trials/docetaxel-in-treating-patients-with-stage-ii-or-stage-iii-prostate-cancer-59820https://curecurrent.com/trials/high-dose-rate-brachytherapy-and-or-intensity-modulated-external-beam-radiation-therapy-for-prostate-cancer-59821https://curecurrent.com/trials/statin-therapy-versus-placebo-prior-to-prostatectomy-59822https://curecurrent.com/trials/vinorelbine-plus-paclitaxel-in-treating-patients-with-metastatic-prostate-cancer-that-is-refractory-to-hormone-therapy-59823https://curecurrent.com/trials/focal-therapy-for-prostate-cancer-a-pilot-study-of-focal-low-dose-rate-brachytherapy-59824https://curecurrent.com/trials/study-of-complementary-therapies-in-men-receiving-radiation-therapy-for-prostate-cancer-a-feasibility-trial-59825https://curecurrent.com/trials/positron-emission-tomography-and-magnetic-resonance-imaging-for-prostate-cancer-59826https://curecurrent.com/trials/doxorubicin-gnrh-agonist-conjugate-aezs-108-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-59827https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-onc1-0013b-in-patients-with-progressive-metastatic-castration-resistant-pros-59828https://curecurrent.com/trials/ari103094-follow-up-study-for-reduce-study-subjects-59829https://curecurrent.com/trials/abiraterone-acetate-and-prednisone-with-or-without-dasatinib-in-treating-patients-with-metastatic-hormone-resistant-pros-59830https://curecurrent.com/trials/comparison-of-duration-of-treatment-interruption-with-or-without-curcumin-during-the-off-treatment-periods-in-patients-w-59831https://curecurrent.com/trials/a-study-of-neoadjuvant-tak-700-and-leuprorelin-acetate-followed-by-surgery-versus-surgery-alone-59832https://curecurrent.com/trials/a-trial-evaluating-two-subcutaneous-injection-techniques-and-intramuscular-administration-of-degarelix-in-patients-with-59833https://curecurrent.com/trials/a-phase-i-feasibility-study-of-an-intraprostatic-psa-based-vaccine-in-men-with-prostate-cancer-with-local-failure-follow-59834https://curecurrent.com/trials/magnetic-resonance-imaging-to-evaluate-prostate-cancer-59835https://curecurrent.com/trials/study-of-weekly-cabazitaxel-for-advanced-prostate-cancer-59836https://curecurrent.com/trials/psa-based-vaccine-and-radiotherapy-to-treat-localized-prostate-cancer-59837https://curecurrent.com/trials/evaluation-of-the-practice-of-the-tep-choline-at-patients-with-prostate-cancer-59838https://curecurrent.com/trials/lapatinib-in-treating-patients-with-prostate-cancer-that-did-not-respond-to-hormone-therapy-59839https://curecurrent.com/trials/phase-iv-study-to-evaluate-bone-mineral-density-in-no-bone-metastatic-prostate-cancer-treated-with-degarelix-59840https://curecurrent.com/trials/a-study-to-evaluate-how-daily-dosing-with-enzalutamide-affects-the-metabolism-of-caffeine-and-dextromethorphan-in-men-wi-59841https://curecurrent.com/trials/drug-drug-interaction-study-with-mdv3100-and-a-cocktail-of-substrates-59842https://curecurrent.com/trials/repeatability-of-positron-emission-tomography-tep-with-fluorom-thyl-18f-dim-thyl-2-hydroxy-thyl-ammonium-59843https://curecurrent.com/trials/spectro-irm-and-evaluation-response-to-prostatic-radiotherapy-59844https://curecurrent.com/trials/sexual-steroids-relationship-between-serum-and-prostatic-tissue-level-59845https://curecurrent.com/trials/calcitriol-in-combination-with-ketoconazole-and-therapeutic-hydrocortisone-in-treating-patients-with-prostate-cancer-59846https://curecurrent.com/trials/calcitriol-and-dexamethasone-before-radical-prostatectomy-in-treating-patients-with-localized-adenocarcinoma-cancer-of-t-59847https://curecurrent.com/trials/cryoablation-therapy-or-radiotherapy-therapy-for-stage-iii-prostate-cancer-59848https://curecurrent.com/trials/endocrine-therapy-with-or-without-cryoablation-for-stage-iv-prostate-cancer-59849https://curecurrent.com/trials/carboplatin-and-paclitaxel-in-patients-with-metastatic-castrate-resistant-prostate-cancer-59850https://curecurrent.com/trials/abiraterone-prednisone-and-hormonal-therapy-before-and-during-radiation-therapy-in-localized-prostate-cancer-59851https://curecurrent.com/trials/a-couple-support-intervention-for-prostate-cancer-59852https://curecurrent.com/trials/cost-efficacy-evaluation-of-robot-assisted-radical-prostatectomy-59853https://curecurrent.com/trials/sipuleucel-t-in-metastatic-castrate-resistant-prostate-cancer-59854https://curecurrent.com/trials/safety-activity-of-p501-as15-vaccine-as-a-first-line-treatment-for-patients-with-hormone-sensitive-prostate-cancer-who-s-59855https://curecurrent.com/trials/sulphate-accumulation-in-prostate-59856https://curecurrent.com/trials/the-value-of-psma-pet-compared-with-multi-parametric-mri-in-the-detection-prostate-lesions-59857https://curecurrent.com/trials/efficacy-and-safety-of-zoledronic-acid-in-the-treatment-of-bone-metastases-related-pain-in-patients-with-prostate-cancer-59858https://curecurrent.com/trials/psa-levels-and-biopsy-samples-after-implant-radiation-and-hormone-therapy-in-patients-with-stage-i-or-stage-ii-prostate-59859https://curecurrent.com/trials/glivec-in-prostate-cancer-patients-with-rising-psa-following-radical-prostectomy-59860https://curecurrent.com/trials/docetaxel-androgen-ablation-and-external-beam-radiation-therapy-in-patients-with-high-risk-localized-prostate-cancer-59861https://curecurrent.com/trials/effect-of-zoledronic-acid-on-circulating-and-bone-marrow-residing-prostate-cancer-cells-in-patients-with-clinically-loca-59862https://curecurrent.com/trials/economic-analyses-of-the-reduce-trial-59863https://curecurrent.com/trials/sequencing-of-sipuleucel-t-and-adt-in-men-with-non-metastatic-prostate-cancer-59864https://curecurrent.com/trials/naf-fdg-pet-mri-in-measuring-response-to-radium-ra-223-dichloride-in-patients-with-metastatic-hormone-resistant-prostate-59865https://curecurrent.com/trials/evaluation-of-new-or-worsening-lens-opacifications-in-men-with-non-metastatic-prostate-cancer-receiving-denosumab-for-bo-59866https://curecurrent.com/trials/study-of-everolimus-added-to-combined-hormonal-and-radiation-therapy-for-high-risk-prostate-cancer-59867https://curecurrent.com/trials/experiences-with-hdr-brachytherapy-in-norway-59868https://curecurrent.com/trials/docetaxel-bevacizumab-and-androgen-deprivation-therapy-after-definitive-local-therapy-for-prostate-cancer-59869https://curecurrent.com/trials/study-to-allow-for-second-treatment-cycle-of-dcvac-in-patients-with-localized-prostate-cancer-59870https://curecurrent.com/trials/phase-ii-study-of-dcvac-pca-added-to-hormone-therapy-for-men-with-metastatic-prostate-cancer-59871https://curecurrent.com/trials/phase-ii-study-of-dcvac-pca-added-after-radical-primary-prostatectomy-for-patients-with-localized-prostate-cancer-59872https://curecurrent.com/trials/68ga-nota-rm26-pet-ct-in-prostate-cancer-patients-59873https://curecurrent.com/trials/pazopanib-hydrochloride-with-or-without-bicalutamide-in-treating-patients-with-prostate-cancer-that-did-not-respond-to-h-59874https://curecurrent.com/trials/phase-ii-study-of-dcvac-pca-added-to-standard-chemotherapy-for-men-with-metastatic-castration-resistant-prostate-cancer-59875https://curecurrent.com/trials/open-label-study-of-sipuleucel-t-in-metastatic-prostate-cancer-59876https://curecurrent.com/trials/to-evaluate-sipuleucel-t-manufactured-with-different-concentrations-of-pa2024-antigen-59877https://curecurrent.com/trials/ga-68-nodaga-mj9-compared-to-f-18-fch-pet-ct-for-prostate-cancer-patients-59878https://curecurrent.com/trials/korean-practice-patterns-for-screening-pca-prostate-cancer-59879https://curecurrent.com/trials/bkm120-in-metastatic-castration-resistant-prostate-cancer-59880https://curecurrent.com/trials/dna-changes-in-patients-with-prostate-cancer-59881https://curecurrent.com/trials/digital-rectal-exam-proficiency-tool-59882https://curecurrent.com/trials/study-of-tissue-and-blood-samples-from-patients-with-recurrent-prostate-cancer-who-received-lapatinib-on-clinical-trial-59883https://curecurrent.com/trials/study-comparing-orteronel-plus-prednisone-in-participants-with-chemotherapy-naive-metastatic-castration-resistant-prosta-59884https://curecurrent.com/trials/incidence-of-fluoroquinolone-resistant-bacteria-in-patients-undergoing-prostate-biopsy-59885https://curecurrent.com/trials/psa-antibody-levels-in-samples-from-patients-with-prostate-cancer-treated-on-protocol-ecog-e9802-59886https://curecurrent.com/trials/a-phase-i-study-of-lbh589-panobinostat-in-combination-with-external-beam-radiotherapy-for-the-treatment-of-prostate-canc-59887https://curecurrent.com/trials/hormone-therapy-and-ipilimumab-in-treating-patients-with-advanced-prostate-cancer-59888https://curecurrent.com/trials/metformin-in-castration-resistant-prostate-cancer-59889https://curecurrent.com/trials/abiraterone-acetate-trial-in-african-american-prostate-cancer-patients-59890https://curecurrent.com/trials/prostate-cancer-genomic-heterogeneity-59891https://curecurrent.com/trials/magnetic-nanoparticle-thermoablation-retention-and-maintenance-in-the-prostate-a-phase-0-study-in-men-59892https://curecurrent.com/trials/focal-recurrent-assessment-and-salvage-treatment-59893https://curecurrent.com/trials/will-erectile-dysfunction-increase-the-risk-of-prostate-cancer-59894https://curecurrent.com/trials/treatment-with-mk0966-for-the-prevention-of-prostate-cancer-0966-201-59895https://curecurrent.com/trials/application-of-high-resolution-diffusion-weighted-mr-imaging-pulse-sequence-in-head-and-neck-and-prostate-cancers-59896https://curecurrent.com/trials/healthy-bones-study-59897https://curecurrent.com/trials/diagnostic-imaging-of-bone-metastases-in-prostate-cancer-patients-59898https://curecurrent.com/trials/the-efficacy-and-safety-of-udenafil-in-patients-with-erectile-dysfunction-after-bilateral-nerve-sparing-radical-prostate-59899https://curecurrent.com/trials/ion-prostate-irradiation-59900https://curecurrent.com/trials/navitoclax-and-abiraterone-acetate-with-or-without-hydroxychloroquine-in-treating-patients-with-progressive-metastatic-c-59901https://curecurrent.com/trials/evaluation-of-transperineal-ultrasound-for-image-guidance-in-the-treatment-of-prostate-cancer-in-men-following-prostatec-59902https://curecurrent.com/trials/calcitriol-mitoxantrone-and-prednisone-in-treating-patients-with-metastatic-prostate-cancer-59903https://curecurrent.com/trials/repurposing-metformin-as-anticancer-drug-in-advanced-prostate-cancer-59904https://curecurrent.com/trials/expression-of-molecular-markers-in-circulating-tumor-cells-of-metastatic-castration-resistant-prostate-cancer-59905https://curecurrent.com/trials/docetaxel-in-treating-patients-with-stage-iv-prostate-cancer-59906https://curecurrent.com/trials/calcitriol-in-treating-patients-with-a-rising-psa-level-following-treatment-for-prostate-cancer-59907https://curecurrent.com/trials/combination-chemotherapy-followed-by-surgery-in-treating-patients-with-localized-prostate-cancer-59908https://curecurrent.com/trials/paclitaxel-poliglumex-and-estradiol-in-treating-patients-with-stage-iv-prostate-cancer-59909https://curecurrent.com/trials/docetaxel-in-treating-patients-with-relapsed-prostate-cancer-59910https://curecurrent.com/trials/sulforaphane-in-treating-patients-with-recurrent-prostate-cancer-59911https://curecurrent.com/trials/acupuncture-in-treating-hot-flashes-in-patients-with-prostate-cancer-59912https://curecurrent.com/trials/pre-prostatectomy-celecoxib-or-placebo-59913https://curecurrent.com/trials/dietary-fat-levels-and-abiraterone-acetate-uptake-in-patients-with-metastatic-hormone-resistant-prostate-cancer-59914https://curecurrent.com/trials/calcitriol-and-carboplatin-in-treating-patients-with-stage-iv-prostate-cancer-that-has-not-responded-to-hormone-therapy-59915https://curecurrent.com/trials/magnetic-resonance-spectroscopic-imaging-study-of-prostatic-fats-to-distinguish-the-difference-between-high-and-low-risk-59916https://curecurrent.com/trials/hyperthermia-plus-radiation-therapy-in-treating-patients-with-nonmetastatic-advanced-prostate-cancer-59917https://curecurrent.com/trials/defining-the-extent-and-grade-of-prostate-cancer-using-dynamic-contrast-enhanced-diffusion-weighted-and-bold-mri-59918https://curecurrent.com/trials/correlation-between-suv-on-18f-fluorocholine-pet-ct-and-gleason-score-in-prostate-cancer-59919https://curecurrent.com/trials/phase-ii-study-of-subcutaneous-injection-depot-of-leuprolide-acetate-in-patient-with-prostate-cancer-59920https://curecurrent.com/trials/online-study-of-colorectal-cancer-and-prostate-cancer-screening-decision-making-59921https://curecurrent.com/trials/effect-of-enzalutamide-dose-reduction-on-fatigue-cognition-and-drug-trough-levels-in-patients-with-prostate-cancer-59922https://curecurrent.com/trials/prostate-cancer-e-health-tutorial-59923https://curecurrent.com/trials/study-to-monitor-the-effects-of-androgen-suppression-treatment-on-the-heart-59924https://curecurrent.com/trials/herbal-therapy-for-treatment-of-recurrent-prostate-cancer-59925https://curecurrent.com/trials/focal-therapy-using-hifu-for-localised-prostate-cancer-59926https://curecurrent.com/trials/17-aag-in-treating-patients-with-metastatic-prostate-cancer-that-did-not-respond-to-previous-hormone-therapy-59927https://curecurrent.com/trials/fish-oil-and-green-tea-extract-in-preventing-prostate-cancer-in-patients-who-are-at-risk-for-developing-prostate-cancer-59928https://curecurrent.com/trials/fdg-positron-emission-tomography-and-computed-tomography-pet-ct-in-metastatic-prostate-cancer-59929https://curecurrent.com/trials/molecular-characterization-of-ctcs-and-ctdna-in-blood-and-plasma-samples-from-patients-with-metastatic-and-or-hormone-re-59930https://curecurrent.com/trials/antibiotic-prophylaxis-for-urinary-catheter-removal-after-radical-prostatectomy-59931https://curecurrent.com/trials/cabazitaxel-at-20-mg-m-compared-to-25-mg-m-with-prednisone-for-the-treatment-of-metastatic-castration-resistant-prostate-59932https://curecurrent.com/trials/swog-9346-hormone-therapy-in-treating-men-with-stage-iv-prostate-cancer-59933https://curecurrent.com/trials/vacuum-erection-device-in-improving-recovery-of-erectile-function-in-patients-with-prostate-cancer-undergoing-surgery-59934https://curecurrent.com/trials/safety-and-efficacy-of-tak-385-for-patients-with-localized-prostate-cancer-59935https://curecurrent.com/trials/study-of-itraconazole-in-castrate-resistant-prostate-cancer-crpc-post-chemotherapy-59936https://curecurrent.com/trials/68ga-dota-bombesin-pet-mri-in-imaging-patients-with-prostate-cancer-59937https://curecurrent.com/trials/safety-study-effectiveness-of-docetaxel-with-rad001-and-bevacizumab-in-men-with-advanced-prostate-cancer-59938https://curecurrent.com/trials/facilitating-participation-in-a-prostate-cancer-risk-assessment-program-59939https://curecurrent.com/trials/predictor-of-early-recovery-on-urinary-continence-after-laparoscopic-radical-prostatectomy-59940https://curecurrent.com/trials/radium-223-dichloride-alpharadin-in-castration-resistant-hormone-refractory-prostate-cancer-patients-with-bone-metastase-59941https://curecurrent.com/trials/character-traits-and-stress-in-suspected-prostate-cancer-59942https://curecurrent.com/trials/use-of-low-dose-ketoconazole-in-prostate-cancer-that-does-not-respond-to-hormone-therapy-and-prior-chemotherapy-59943https://curecurrent.com/trials/leuplin-sr-11-25-mg-injection-kit-specified-drug-use-survey-long-term-use-survey-in-prostate-cancer-patients-96-weeks-59944https://curecurrent.com/trials/safety-and-pharmacokinetics-study-of-odm-201-in-castrate-resistant-prostate-cancer-59945https://curecurrent.com/trials/study-of-effectiveness-of-imc-a12-antibody-combined-with-hormone-therapy-prior-to-surgery-to-treat-prostate-cancer-59946https://curecurrent.com/trials/relative-bioavailability-study-of-bicalutamide-50-mg-tablet-and-casodex-following-a-50-mg-dose-in-healthy-subjects-under-59947https://curecurrent.com/trials/relative-bioavailability-study-of-bicalutamide-50-mg-tablet-and-casodex-following-a-50-mg-dose-in-healthy-subjects-under-59948https://curecurrent.com/trials/study-of-abiraterone-acetate-in-patients-with-advanced-prostate-cancer-59949https://curecurrent.com/trials/an-open-label-extension-study-of-psma-adc-2301-in-mcrpc-59950https://curecurrent.com/trials/a-study-of-psma-adc-in-subjects-with-metastatic-castration-resistant-prostate-cancer-mcrpc-59951https://curecurrent.com/trials/abiraterone-rechallenge-study-for-crpc-patients-59952https://curecurrent.com/trials/bicalutamide-and-raloxifene-in-treating-patients-with-metastatic-or-hormone-refractory-prostate-cancer-59953https://curecurrent.com/trials/pet-ct-imaging-study-of-the-safety-and-diagnostic-performance-of-68ga-rm2-in-patients-with-primary-prostate-cancer-59954https://curecurrent.com/trials/autologous-immune-cell-therapy-in-combination-with-lhrh-a-in-patients-with-mcrpc-59955https://curecurrent.com/trials/mri-in-active-surveillance-of-prostate-cancer-59956https://curecurrent.com/trials/olive-oil-v-prostate-cancer-foundation-diet-for-treatment-of-prostate-cancer-59957https://curecurrent.com/trials/targeted-prostate-biopsy-using-a-novel-mri-ultrasound-fusion-device-59958https://curecurrent.com/trials/phase-i-sodium-selenite-in-combination-with-docetaxel-in-castration-resistant-prostate-cancer-59959https://curecurrent.com/trials/feasibility-study-of-ultrasound-elastography-detecting-prostate-cancer-59960https://curecurrent.com/trials/carbon-11-acetate-and-fludeoxyglucose-f-18-pet-scan-of-the-bone-in-patients-with-metastatic-prostate-cancer-that-has-spr-59961https://curecurrent.com/trials/two-dose-level-evaluation-of-nx-1207-for-the-treatment-of-low-risk-localized-t1c-prostate-cancer-59962https://curecurrent.com/trials/a-study-in-patients-with-metastatic-prostate-cancer-to-assess-how-the-drug-eligard-affects-certain-markers-in-blood-and-59963https://curecurrent.com/trials/study-to-assess-efficacy-and-safety-of-zoledronic-acid-and-the-value-of-markers-of-bone-resorption-in-the-prediction-of-59964https://curecurrent.com/trials/assessment-of-the-efficacy-tolerability-and-pharmaco-economic-impact-of-zoledronic-acid-treatment-in-prostate-cancer-wit-59965https://curecurrent.com/trials/study-of-ogx-011-given-prior-to-radical-prostatectomy-in-patients-with-localized-prostate-cancer-59966https://curecurrent.com/trials/docetaxel-prednisone-with-or-without-radiation-for-castrate-resistant-prostate-cancer-59967https://curecurrent.com/trials/efficacy-and-safety-of-leuprolide-acetate-22-5-mg-depot-in-treatment-of-prostate-cancer-59968https://curecurrent.com/trials/improving-energy-balance-in-men-with-prostate-cancer-59969https://curecurrent.com/trials/prospective-clinical-utility-study-to-assess-the-impact-of-decipher-on-treatment-decisions-after-surgery-59970https://curecurrent.com/trials/prostate-cancer-study-in-men-who-have-failed-first-line-androgen-deprivation-therapy-59971https://curecurrent.com/trials/g-202-in-the-neoadjuvant-setting-followed-by-radical-prostatectomy-in-patients-with-prostate-cancer-59972https://curecurrent.com/trials/diet-and-exercise-based-counseling-program-compared-with-a-standard-counseling-program-in-patients-with-early-stage-pros-59973https://curecurrent.com/trials/low-fat-diet-and-or-flaxseed-in-preventing-prostate-cancer-59974https://curecurrent.com/trials/ixabepilone-compared-with-mitoxantrone-and-prednisone-in-treating-patients-with-refractory-metastatic-prostate-cancer-59975https://curecurrent.com/trials/study-to-evaluate-zoledronic-acid-on-quality-of-life-and-skeletal-related-events-as-adjuvant-treatment-in-patients-with-59976https://curecurrent.com/trials/exercise-intervention-metabolic-syndrome-prostate-cancer-black-men-59977https://curecurrent.com/trials/open-label-phase-iv-clinical-trial-to-evaluate-the-safety-and-tolerability-of-zoledronic-acid-in-patients-with-prostate-59978https://curecurrent.com/trials/effects-of-urinary-bladder-hypertrophy-on-urge-urine-incontinence-after-radical-prostatectomy-59979https://curecurrent.com/trials/the-use-of-zoledronic-acid-in-men-on-androgen-deprivation-therapy-for-prostate-cancer-with-preexisting-osteoporosis-59980https://curecurrent.com/trials/impact-on-instructional-video-on-patients-compliance-with-preparation-during-ct-planning-for-prostate-cancer-59981https://curecurrent.com/trials/safety-and-tolerability-of-odm-201-in-castrate-resistant-prostate-cancer-extension-study-to-study-3104001-59982https://curecurrent.com/trials/trial-of-rnactive-derived-prostate-cancer-vaccine-in-metastatic-castrate-refractory-prostate-cancer-59983https://curecurrent.com/trials/provide-expanded-access-to-mdv3100-and-monitor-its-safety-in-patients-with-progressive-castration-resistant-prostate-can-59984https://curecurrent.com/trials/retrograde-perfusion-sphinterometry-and-autologous-sling-to-improve-urinary-continence-in-robotic-radical-prostatectomy-59985https://curecurrent.com/trials/epo906-therapy-in-patients-with-prostate-cancer-59986https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-estetrol-in-healthy-men-59987https://curecurrent.com/trials/a-phase-2-study-with-mip-1404-in-men-with-high-risk-pc-scheduled-for-rp-and-eplnd-compared-to-histopathology-59988https://curecurrent.com/trials/hydroxychloroquine-in-blocking-autophagy-in-patients-with-prostate-cancer-undergoing-surgery-or-active-surveillance-59989https://curecurrent.com/trials/a-pilot-study-to-assess-the-follow-up-of-prostate-cancer-patients-who-have-undergone-radiotherapy-treatment-59990https://curecurrent.com/trials/taxotere-prednisone-plus-sunitinib-in-chemotherapy-na-ve-hormone-refractory-prostate-cancer-patients-59991https://curecurrent.com/trials/switch-study-of-the-prednisone-to-dexamethasone-change-in-mcrpc-patients-treated-with-abiraterone-59992https://curecurrent.com/trials/pelvic-floor-muscles-training-in-men-undergoing-radiotherapy-for-prostate-cancer-randomized-controlled-trial-59993https://curecurrent.com/trials/health-interventions-in-men-undergoing-radical-prostatectomy-59994https://curecurrent.com/trials/a-study-to-measure-needle-bending-and-changes-in-prostate-shape-during-a-prostate-seed-implant-59995https://curecurrent.com/trials/effects-of-peep-on-intracranial-and-intraocular-pressure-in-robot-assisted-laparoscopic-radical-prostatectomy-59996https://curecurrent.com/trials/phase-1-study-to-evaluate-the-pharmacokinetics-and-safety-following-sc-administration-of-dwj108j-in-patients-with-prosta-59997https://curecurrent.com/trials/prospective-study-to-compare-a-limited-versus-extended-pelvic-lymphadenectomy-during-prostatectomy-59998https://curecurrent.com/trials/combination-of-cabazitaxel-with-prednisolone-with-primary-prophylaxis-with-peg-g-csf-in-treatment-of-patients-with-prost-59999https://curecurrent.com/trials/combined-intravenous-diazepam-local-periprostatic-nerve-block-for-prostate-biopsy-60000